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ABSTRACT 
One bout of exercise can lead to a long-lasting increase in insulin-stimulated glucose 
transport and a sustained increase in the phosphorylation of Akt Substrate of 160 kDa 
(AS160), a signaling protein proposed to be important for the post-exercise improvement in 
insulin sensitivity.  The aims of the studies in this dissertation were to evaluate the roles of: 
1) the Kallikrein-Kininogen System (KKS) in the increase in post-exercise insulin-stimulated 
glucose transport in rodent skeletal muscle; and 2) specific protein kinases and phosphatases 
for the sustained AS160 phosphorylation after acute exercise.  KKS, previously proposed to 
be necessary for increased insulin-stimulated glucose transport after in vitro contractions, was 
studied with two genetic rodent models with deficits in KKS proteins: 1) mice null for the B2 
receptor of bradykinin (B2R), and 2) rats deficient for plasma kininogen.  The results 
indicated that neither the B2R in mice nor normal plasma kininogen levels in rats was 
essential for the post-exercise increase in insulin-stimulated glucose transport, suggesting that 
an intact KKS is not essential for enhanced muscle insulin sensitivity after exercise.  The 
second part of the dissertation evaluated proteins regulating sustained AS160 
phosphorylation after exercise.  Results from these experiments demonstrated sustained 
phosphorylation of the Thr642 and Ser588 phospho-sites of AS160 in rat skeletal muscle 3-4 
hours post-exercise.  Each of the four known AS160 kinases (AMPK, Akt, RSK, and SGK) 
were studied, but only AMPK had greater phosphorylation immediately after exercise, and 
none had greater sustained phosphorylation in 3-4 hours post-exercise.  Each of the four most 
abundant skeletal muscle serine/threonine phosphatases (PP1, PP2A, PP2B, and PP2C) was 
found to dephosphorylate AS160 in a cell-free assay, but only PP1 and PP2C were associated 
with AS160 based on co-immunoprecipitation analysis.  PP1 and PP2C association with 
xvii 
 
AS160 were unaltered post-exercise.  The results suggest: 1) AMPK is likely to participate in 
the immediate post-exercise increase in AS160 phosphorylation; 2) sustained AS160Thr642 
and AS160Ser588 phosphorylation 3-4 hours post-exercise is not attributable to greater 
phosphorylation of the known AS160 kinases; and 3) PP1 and PP2C may modulate AS160 
phosphorylation in skeletal muscle because they are associated with AS160 and able to 
dephosphorylate AS160Thr642 and AS160Ser588.   
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CHAPTER I 
 
INTRODUCTION 
 
It has been known for nearly 30 years that a single exercise bout can lead to a 
subsequent increase in insulin sensitivity for skeletal muscle glucose transport (11).  
However, the molecular mechanisms by which exercise leads to increases in post-
exercise insulin-stimulated glucose transport in skeletal muscle are still not fully 
understood.  Akt Substrate of 160kDa (AS160), a key signaling protein for regulating 
glucose transport (2, 7, 12, 13), has been shown to respond to acute exercise with 
sustained phosphorylation in skeletal muscle, and this persistent increase in AS160 
phosphorylation tracks with the long-lasting increase in insulin-stimulated glucose 
transport (1). 
The primary goals of this research were 1) to evaluate the idea that elements of 
the Kallikrein-Kininogen System (KKS) may participate in the events that trigger the 
post-exercise increase in insulin-stimulated glucose transport, and 2) to characterize the 
post-exercise activation states of several kinases and the regulation of serine/threonine 
phosphatases that can contribute to increased AS160 phosphorylation on specific 
phospho-sites after exercise which is concomitant with the persistent post-exercise 
increase in insulin-stimulated glucose transport.    
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The first two studies used genetic models to probe the potential relationship of the 
KKS and post-exercise insulin sensitivity.  Exercise has been shown to increase blood 
levels of bradykinin, a nonapeptide which is produced from the enzymatic lysis of 
kininogen, a plasma protein that is secreted by the liver.  Several lines of evidence 
suggest that the KKS can influence glucoregulation and insulin action, at least under 
some conditions.  For example, inhibition of kininases which degrade bradykinin can 
improve insulin sensitivity (4, 9, 15, 16), mice that are null for the B2 receptor of 
bradykinin (B2R) are insulin resistant (6), and rats with a congenital deficiency of plasma 
kininogen are characterized by moderate insulin resistance (3).  Therefore, it seemed 
possible that some effects of exercise on muscle glucose uptake may involve elements of 
the KKS, including the B2R and circulating kininogen.    
 
Study 1: The B2 receptor of bradykinin is not essential for the post-exercise increase in 
glucose uptake by insulin-stimulated mouse skeletal muscle 
In order to understand the role of the B2 receptor of bradykinin, Study 1 used 
genetically modified mice null for the B2R to test the idea that this receptor may be 
important for the post-exercise increase in insulin action.    
 
Study 2: Post-exercise skeletal muscle glucose transport is normal in kininogen-deficient 
rats 
To more directly assess the role of kininogen in post-exercise increases in insulin 
sensitivity in skeletal muscle, Study 2 used rats deficient in plasma kininogen to 
determine if normal circulating kininogen levels are required for the sustained increase in 
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insulin-stimulated glucose transport in skeletal muscle after exercise.  Furthermore, this 
study evaluated the insulin-independent effect of exercise on skeletal muscle glucose 
transport as it has been suggested that activation of the KKS may play a role in the 
exercise-induced increase in insulin-independent glucose transport (8, 14) 
 
Study 3: Mechanisms for the prolonged post-exercise increase in AS160 
phosphorylation: Roles of protein kinases and phosphatases 
  Sustained AS160 phosphorylation in rat skeletal muscle after exercise was 
previously found on the Thr642 site, a site known to be important for insulin-stimulated 
GLUT4 translocation.  However, the other important site, Ser588, had not been 
investigated in rat epitrochlearis muscle under similar conditions.  Accordingly, Study 3 
evaluated the Ser588 phospho-site of AS160 to determine if a single exercise session 
results in sustained phosphorylation of this site in skeletal muscle.  Additionally, Study 3 
investigated the mechanisms that account for this sustained increase in AS160 
phosphorylation post-exercise.  The four known kinases of AS160 (Akt, AMPK, RSK, 
and SGK) as well as p70S6K, a kinase whose consensus motif implicates AS160 as a 
possible substrate (5, 10), were evaluated to determine if they have greater 
phosphorylation on phospho-sites essential to their activity three hours post-exercise 
versus sedentary controls concomitant with elevated AS160 phosphorylation.  Finally, as 
there are no known phosphatases of AS160, Study 3 evaluated the four most abundant 
skeletal muscle serine/threonine phosphatases (PP1, PP2A, PP2B, and PP2C) on their 
ability to dephosphorylate AS160, their association with AS160, and if their association 
with AS160 is altered by prior exercise.      
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CHAPTER II 
 
REVIEW OF LITERATURE 
 
Importance of Skeletal Muscle Glucose Transport 
Insulin resistance (a subnormal physiologic response to normal insulin 
concentration) by skeletal muscle is a primary defect in the progression of type 2 diabetes 
mellitus (non-insulin dependent diabetes mellitus, NIDDM).  In 2007, Type-2 diabetes 
mellitus represented 90 to 95% of all diabetes cases in the United States, totaling to more 
than 17.5 million Americans, increasing at a rate of ~1 million new cases each year, and 
costing $174 billion (1, 149). Insulin resistance and hyperinsulinemia in people who do 
not become diabetic are linked to a myriad of pathologies such as atherogenesis, 
hypertension, cardiovascular disease, cancer, and cognitive dysfunction (54, 70, 105).  
Skeletal muscle accounts for 85% of insulin-stimulated blood glucose disposal (46), and 
glucose transport is a rate-limiting step in muscle glucose metabolism (185).  
Additionally, exercise can positively regulate glucose homeostasis by increased glucose 
transport independent of insulin and enhance insulin’s ability to increase glucose 
transport.  The ability of exercise to enhance insulin sensitivity is often suggested to be a 
major factor supporting epidemiological evidence showing regular exercise prevents or 
delays type 2 diabetes onset (99, 163).   
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In addition to the health benefits, increased skeletal muscle glucose transport 
during exercise provides a means for blood glucose to contribute as an energy source as 
well as aid in blood glucose entering the muscle cells to be stored as glycogen after 
exercise has ceased.  Because repeated bouts of exercise and/or strenuous exercise can 
deplete muscle glycogen, rapid muscle glycogen replenishment from increased skeletal 
muscle glucose uptake is especially important for athletes who wish to maintain 
performance (36, 92).   
 
Effect of Insulin on Glucose Transport 
Nearly 60 years ago, Levine and colleagues first showed that insulin’s action, 
which leads to cellular glucose uptake, occurs at the cell membrane rather than on 
intracellular enzymes (112).  Subsequently, insulin has been shown to increase glucose 
transport by increasing glucose transporter 4 (GLUT4) protein translocation to the cell 
surface membranes (11, 67, 110, 169, 180).  In muscle fibers, these cell-surface 
membranes are the sarcolemma and T-tubules.  As shown in Figure 2.1, insulin signaling 
begins when insulin binds to the insulin receptor (IR) and causes receptor 
autophosphorylation on multiple tyrosine residues (21, 157, 173, 181).  The increased 
tyrosine kinase receptor activity of IR leads to docking of insulin receptor substrate (IRS) 
proteins (IRS1 and IRS2 in skeletal muscle), which are also phosphorylated on specific 
tyrosine residues (123, 141, 155, 172).  Phosphatidylinositol 3-kinase (PI3K) binds to 
tyrosine phosphorylated IRS proteins, inducing a conformational change in PI3K and 
increasing the kinase activity of PI3K (22).  PI3K phosphorylates phosphatidylinositol-
(4,5)-bisphosphate (PIP2) in the phospholipid bilayer to produce phosphatidylinositol-
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(3,4,5)-trisphosphate (PIP3) (164, 165). PIP3 recruits proteins, including 
(phosphoinositide-dependent kinases-1) PDK1 and Akt, through binding of their 
pleckstrin homology (PH) domains to PIP3 (4, 111).  Akt is phosphorylated and activated 
by PDK1 at Thr308 within the T loop of the catalytic domain (2, 3, 152) and by 
mammalian target of rapaymycin complex-2 (mTORC-2) at Ser 473 in a noncatalytic 
hydrophobic motif (144, 145).  Activated Akt phosphorylates many substrates, including 
Akt substrate of 160 kDa (AS160) also known as tre-2/USP6, BUB2, cdc16 domain 
family, member 4 (TBC1D4). AS160 phosphorylation has been implicated in insulin-
stimulated GLUT4 translocation and glucose transport (94, 143).   
 
Kallikrein-Kininogen System:  Exercise and Glucose Metabolism 
A number of studies have demonstrated that the Kallikrein-Kininogen System 
(KKS) can benefit glucoregulation and insulin sensitivity.  Bradykinin, a 9-amino peptide 
product of the KKS, has been shown to be able to induce an increase in GLUT4 
translocation and glucose uptake of primary adipocytes, L6 myotubes, and cardiac 
muscle cells (89, 98, 133).  Angiotensin-converting enzyme (ACE) inhibitors that 
antagonize the enzymes that degrade bradykinin and reduce antiogensin II concentration 
are able to improve insulin sensitivity (76).  The benefits of ACE inhibitors for 
glucoregulation may be partly the result of hemodynamic mechanisms, but there is also 
evidence for direct effects of bradykinin on isolated cell or muscle glucose uptake (8, 79, 
89, 103, 118).  Bradykinin binding to its receptor, bradykinin 2 receptor (B2R), which is 
expressed on skeletal muscle fibers (131), has been implicated in increased glucose 
uptake and improved insulin sensitivity (28, 48, 73, 77, 78, 118).   Mice that are null for 
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the bradykinin 2 receptor (B2R) are characterized by insulin resistance during a 
euglycemic-hyperinsulinemic clamp (51).  Furthermore, rats that are deficient in plasma 
kininogen, a protein that is a precursor for bradykinin, are also insulin resistant during a 
euglycemic-hyperinsulinemic clamp (41).   
It has also been documented that exercise or muscle contraction can activate the 
KKS (Figure 2.2).  Kallikrein, a key enzyme for the KKS, circulates in an inactive state 
(9, 10, 146).  Bradykinin is a proteolytic product of activated kallikrein action on its 
substrate which is a plasma protein known as kininogen (10). Plasma kallikrein activity is 
increased following exercise in rats (166), and exercise can elevate circulating bradykinin 
concentration (12, 98, 109, 151, 154, 170).      
Although exercise can activate bradykinin production, and bradykinin can 
positively affect muscle glucose uptake, a role of bradykinin on the post-exercise increase 
in insulin-stimulated glucose transport has not been established.   Dumke et al. (52) 
studied the role of various proteins in the KKS in an attempt to elucidate their role on 
insulin-stimulated glucose transport after muscle contractions.  The KKS has several 
characteristics that suggest it may include the serum factor(s) believed to be required for 
the increase in insulin-stimulated glucose transport after in vitro contraction of isolated 
skeletal muscle in serum (25, 62).  Bradykinin is derived from a circulating protein 
(kininogen) with a molecular mass greater than 10 kDa (10, 114), consistent with the 
results of Gao et al. (62) who provided evidence that a serum protein larger than 10 kDa 
was essential for the post-contraction increase in insulin-stimulated glucose transport.  
Dumke et al. (52) reported that contraction of isolated rat epitrochlearis muscles in the 
presence of either kallikrein inhibitors in rat serum or kallikrein deficient human plasma 
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led to modest attenuation of the post-contraction increase in insulin-stimulated glucose 
transport compared to muscles performing contraction in  untreated rat serum or normal 
human plasma.  These results suggested that kallikrein may be essential for the full effect 
of prior contraction on insulin-stimulated glucose transport.   However, they also found 
that muscles contracted in serum-free buffer supplemented with bradykinin did not have 
enhanced insulin-stimulated glucose transport 3 hours post-contraction.  Additionally, 
supplementing rat serum with a bradykinin receptor antagonist did not reduce the insulin-
stimulated glucose transport three hours after contraction.  Interpretation of the results 
with bradykinin supplementation or bradykinin antagonists must be interpreted with 
caution because bradykinin is very labile, so the bradykinin concentration in the 
incubation media was uncertain. 
Regardless, it is important to consider recent evidence suggesting that the 
mechanism for increased insulin-stimulated glucose transport after in vitro contraction 
may not be identical to the mechanism for enhanced insulin-mediated glucose transport 
after in vivo exercise.  Funai et al. (60) using both an exercise protocol and an electrical 
stimulation isolated muscle contraction protocol that alone increased insulin-stimulated 
glucose transport ~3 hours later showed that the combination of prior exercise followed 
by electrical stimulation had an additive effect on the subsequent increase in insulin-
stimulated glucose transport.  This result suggested that the in vivo exercise and in vitro 
electrical stimulation protocols used by Funai et al. (60) may amplify insulin-stimulated 
GT through distinct mechanisms.  In this context, and given that in vivo exercise can 
activate the KKS and that the KKS is implicated in improved insulin sensitivity provides 
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a rationale for evaluating the effects of in vivo exercise on insulin-stimulated glucose 
transport in genetic models in which key elements of the KKS are modified. 
 
AS160’s Regulation and Role in Glucose Metabolism 
 The gene encoding AS160 was discovered and named TBC1D4 during the 
creation of a cDNA library for the human brain and comparing the gene products based 
on homology to known proteins and sequence motifs in various species, including mice 
(124).  The regulation of AS160 by insulin and AS160’s functional role for controlling 
glucose transport remained unknown until they were recognized by Gus Lienhard’s group 
who used the Akt consensus phosphorylation motif RXRXXpS/T (X is any amino acid) 
to identify novel Akt substrates that were responsive to insulin.  Kane et al. (94) used the 
phospho (Ser/Thr)-Akt substrate (PAS) antibody, which recognizes the Akt consensus 
motif to detect previously unknown Akt substrates in 3T3-L1 adipocytes stimulated with 
insulin.  They identified Akt Substrate of 160 kDa (AS160) as a protein that becomes 
phosphorylated in response to insulin and demonstrated that AS160 was identical to 
TBC1D4.  Using 3T3-L1 adipocytes, they also provided evidence of insulin-stimulated 
AS160’s role for increasing cell-surface GLUT4.  This protein is found not only in 
adipose tissue, but it is also expressed in other tissues including brain, pancreas, and 
skeletal muscle (95).  Furthermore, AS160 in rat skeletal muscle was shown to be 
phosphorylated in response to either insulin or contractile activity (18).  Phosphomotifs 
and domain regions in AS160 are conserved across mouse, rat, and human skeletal 
muscle and include six putative Akt phosphomotifs (Ser318, Ser341, Ser570, Ser588, 
12 
 
Thr642, and Thr751), two phospho-tyrosine domains (PTB), a Rab GTPase activating 
protein (RabGAP) domain, and a calmodulin-binding domain (CBD) (94).   
AS160 contains a RabGAP domain that can regulate Rab-GTP formation (94, 117, 
143).  Rab proteins are involved in membrane vesicular trafficking and can exist either in 
an active GTP-bound form or in an inactive GDP-bound form (47, 129, 130, 182).  
Unphosphorylated AS160 has an active RabGAP domain that leads to GTP hydrolysis 
and therefore, inhibits Rab activation. Phosphorylation of AS160 inactivates the RabGAP 
domain leading to an inhibition of GTP hydrolysis and therefore, activates target Rabs 
and causes Rab-mediated GLUT4 translocation.  In other words, AS160’s effect on 
GLUT4 may be compared to a “brake,” in which unphosphorylated, activated AS160 
restrains GLUT4 and insulin-stimulated phosphorylation of AS160 inactivates the protein, 
“releasing the brake” (26, 139).  Insulin-stimulated AS160 phosphorylation was shown to 
occur in a PI3K-dependent manner in adipocytes (143) and later in rat skeletal muscle 
(18) using the PI3K inhibitor wortmannin. 
Later studies expressed AS160 containing point mutations on one or more of the 
Akt phosphomotifs (with Ser/Thr substituted by Ala to prevent phosphorylation) in 3T3-
L1 cells.  These studies provided evidence that some of these Akt-phosphosites were 
important for insulin-stimulated GLUT4 translocation (143).  Overexpression of AS160 
containing mutations at four Akt phosphomotifs (AS160-4P; Ser318, Ser588, Thr642, 
Thr751) reduced insulin-mediated GLUT4 translocation by ~80% in adipocytes.  The 
inclusion of mutations on two additional Akt phosphomotifs (Ser341 and Ser570; AS160-
6P) did not result in further reduction in GLUT4 translocation (143).  The PAS antibody 
has high affinity for phosphorylated Thr642, lower affinity for phosphorylated Ser588, 
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and very little, if any, affinity for any of the other insulin-regulated Akt phosphomotifs in 
AS160 (64, 143).  Preventing insulin-stimulated phosphorylation of AS160 on 
phosphosites targeted by AS160-4P partially blocked insulin-stimulated glucose uptake 
and this has been confirmed in other models using AS160-4P (40% reduction in L6 cells 
(90) and 50% reduction in skeletal muscle (102)). These results suggest that other 
mechanisms in addition to AS160 phosphorylation are involved in insulin-stimulated 
glucose uptake. 
 An AS160 mutation that targeted the GAP domain in which a key amino acid was 
changed (Arg973 substituted for a Lys; AS160-R/K) resulted in elimination of the GAP 
activity of AS160.  Overexpression of AS160-R/K in 3T3-L1 adipocytes (143) exhibited 
no significant difference between basal and insulin-stimulated GLUT4 translocation 
compared to WT AS160. Additionally, overexpression of an AS160-4P and R/K double 
mutant in adipocytes, compared to AS160-R/K, exhibited similar GLUT4 translocation 
upon insulin stimulation (143).  Goodyear’s group followed up this study by 
overexpressing AS160-R/K in mouse skeletal muscle and found that the mutant caused 
increased insulin-stimulated glucose uptake compared to AS160-4P upon a glucose 
challenge (102). Overexpression of an AS160-4P and R/K double mutant in mouse 
skeletal muscle, compared to AS160-R/K, exhibited similar glucose uptake upon glucose 
challenge (102). These results suggest that the double mutant rescues insulin-stimulated 
glucose uptake of the AS160-4P, and that the activity of AS160’s GAP domain acts to 
restrain or inhibit glucose uptake.  
 AS160 has been shown to be associated with 14-3-3 proteins (132).  14-3-3 
proteins interact with phosphorylated serine and threonine residues, and they have a 
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variety of functions including altering protein conformation, protect from protein 
degradation, affect subcellular distribution of target proteins, inhibit interaction with 
other proteins, and provide a cellular scaffolding (17).  In 3T3-L1 adipocytes (132) and 
skeletal muscle (85, 86, 161), 14-3-3 association with AS160 increases in response to 
insulin stimulation.  Mutation studies in 3T3-L1 adipocytes using AS160-4P or AS160-
Thr642 mutation to alanine (T642A), but not Ser318, Ser341, or Ser588, resulted in a 
lack of association of 14-3-3 to AS160, which was accompanied with decreased insulin-
stimulated GLUT4 translocation.  These data suggested that 14-3-3 binding is important 
for insulin-stimulated glucose transport and that 14-3-3 appears to interact with the 
Thr642 site of AS160.  These findings were supported by various studies in human 
skeletal muscle from before and after the use of a hyperinsulinameic-euglycemic clamp 
showing 14-3-3 binding capacity of AS160 is increased in insulin-stimulated muscle (85, 
86, 161). 
In summary, the AS160 mutation studies suggest the following: 1) the active 
RabGAP domain of AS160 inhibits GLUT4 translocation, 2) phosphorylation of AS160 
induces insulin-stimulated inactivation of the RabGAP domain, possibly secondary to 14-
3-3 binding to AS160, and 3) phosphorylation-mediated inactivation of the RabGAP 
domain of AS160 is essential for insulin-stimulated GLUT4 translocation and glucose 
uptake. 
 
Effect of Exercise on Insulin-independent Glucose Transport 
 In 1953, Goldstein and Levine showed in dogs and rats that, independent of 
insulin, contracting muscles can lead to subsequent muscle glucose uptake (65).  Today, 
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it is well known that a single bout of exercise can increase glucose transport during and 
immediately after exercise, independent of insulin.  The exercise-induced glucose 
transport that occurs in the absence of insulin, insulin-independent glucose transport, 
begins to reverse after the completion of in vivo exercise or in vitro muscle contraction.  
Most of the effects of insulin-independent glucose transport are lost by 1-3 hours post-
exercise.   
 The mechanism of action of insulin-independent glucose transport from exercise 
has been suggested to result from the cumulative effects of several exercise-induced 
events.  Results from a number of studies have supported the idea that the increase in 
cytosolic calcium in the contracting muscle fibers (81-84) and activation of 5’-AMP-
activated protein kinase (AMPK) (66, 74, 75, 106, 174, 175) are key elements of this 
insulin-independent effect of exercise.  Experiments using isolated muscles from mice 
expressing dominant negative AMPK had a ~30% decrease, versus wildtype, in 
contraction-stimulated glucose uptake suggesting that AMPK only partially accounted for 
the increased glucose uptake from contraction (122).  Another study using a muscle-
specific LKB1 (an AMPK kinase) knockout found that contraction-stimulated activation 
was completely eliminated, and glucose uptake (in situ) was reduced by ~50% compared 
to wildtype littermate controls (140).  Wright et al. (179) provided evidence from 
experiments using isolated rat skeletal muscle that calcium, acting through calcium-
calmodulin dependent protein kinase (CAMK), accounted for half of the contraction-
stimulated increase in glucose transport, with AMPK-related mechanisms accounting for 
the remainder of the increase.   
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Post-Exercise Effect on Insulin-stimulated Glucose Transport 
A single bout of exercise can enhance insulin-stimulated glucose transport 
(insulin-dependent glucose transport).  This post-exercise increase in insulin-stimulated 
glucose transport can last 1-48 hours after cessation of exercise.  The post-exercise 
increase in insulin-stimulated glucose transport 3 hours after acute exercise is attributed 
to increased insulin-stimulated GLUT4 cell surface localization (72) without increased 
total GLUT4 abundance (23).   
The results of many studies have indicated that the increase in insulin-stimulated 
glucose transport after acute exercise occurs without elevation of key upstream insulin 
signaling events (Figure 2.3).  Prior exercise has been reported to not affect the following 
insulin signaling steps: 1) IR binding (14-16, 186), 2) IR tyrosine phosphorylation (30, 72, 
87, 160, 178), 3) IR tyrosine kinase activity (159, 160, 176, 178), 4) IRS tyrosine 
phosphorylation (72, 87, 177, 178, 183), 5) IRS-PI3K association (37, 56, 159, 177, 178), 
6) Akt serine phosphorylation (5, 30, 56, 71, 159, 176), 7) Akt threonine phosphorylation 
(61, 71), and 8) Akt activity (61). 
In contrast to upstream insulin signaling steps, AS160 phosphorylation on sites 
recognized by the PAS antibody (PAS-AS160) is greater in epitrochlearis muscles from 
exercised rats (3-4 hours post-exercise) compared to sedentary controls (5).  Funai et al. 
(61) later showed that Thr642 phosphorylation on AS160, which previous studies have 
showed accounts for a majority of PAS signaling (143), is greater in epitrochlearis 
muscles from exercised rats (~3 hours post-exercise) compared to sedentary controls. In 
both cases, this post-exercise compared to sedentary increase of PAS-AS160 was evident 
both in muscles that were not incubated with insulin (i.e. basal incubation) and that were 
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incubated with insulin.  When the insulin-stimulated increase above basal was estimated 
by subtracting basal values from insulin-stimulated values, this calculated delta insulin 
value was not different for exercised versus sedentary muscles.  These results indicated 
that the sustained increase in PAS-AS160 was evident in the absence of insulin, and was 
not because of increased insulin-induced AS160 phosphorylation.  Funai et al. (61) later 
extended these results by demonstrating that the increased AS160 phosphorylation (using 
either anti-PAS or a pT642-site specific antibody) was increased concomitant with 
enhanced insulin-stimulated glucose transport up to 27 hours after exercise.  It has been 
speculated that the insulin-independent increase in AS160 after exercise may eliminate 
AS160’s restraint on intracellular GLUT4 exocytosis and make the GLUT4 vesicles more 
susceptible to subsequent insulin-stimulated recruitment and fusion with cell surface 
membranes (24). 
AS160 phosphorylation after exercise has also been studied in humans by analysis 
of biopsies of recruited muscles.  Two studies in humans found increased PAS-AS160 
several hours after acute exercise (50, 150).  In another study, PAS-AS160 was not 
observed to be increased after an exercise protocol that did not elicit an improvement in 
insulin sensitivity three hours post-exercise, consistent with the idea that the sustained 
increase in AS160 phosphorylation is important for the post-exercise increase in insulin 
action (85).   Finally, 4 hours after one-legged exercise, AS160 phosphorylation at Ser 
318, Ser341, and Ser751 (and Ser588 tended to increase) were all increased compared to 
the resting control muscles from the unexercised leg.  Following a euglycemic-
hyperinsulinemic clamp at ~5.5 hours post-exercise, insulin-stimulated glucose uptake 
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was increased, and the same AS160 phosphosites showed increased phosphorylation 
compared to the resting control muscle.   
The reversal of the post-exercise increase in insulin sensitivity appears to be 
altered by dietary carbohydrate consumption after exercise.  The post-exercise increase in 
insulin sensitivity in epitrochlearis muscle can be maintained for 48 hours if the rat does 
not eat carbohydrate.  Decreased muscle glycogen has been suggested to contribute to the 
increased insulin sensitivity following exercise (187).  However when rats were fed a 
high-fat, carbohydrate-free diet for 48 hours after exercise, the exercised rats showed 
increased insulin-stimulated glucose transport in their epitrochlearis muscles even though 
the muscle glycogen levels had returned to levels similar to unexercised controls (27).  
Therefore, a sustained reduction in muscle glycogen concentration below sedentary 
values was not essential for the persistent post-exercise increase in insulin-stimulated 
glucose transport under these conditions.  However, if rats consumed a high carbohydrate 
diet for 18 hours after exercise, resulting in a muscle glycogen concentration 50% greater 
than normal resting concentration (supercompensation of muscle glycogen), the enhanced 
insulin-stimulated glucose transport was completely reversed (27).  Therefore, glycogen 
supercompensation may be involved in the mechanism related to the reversal of the post-
exercise increase in muscle insulin sensitivity.  There is also evidence for a relationship 
between post-exercise diet and sustained post-exercise AS160 phosphorylation.  Upon 
refeeding of high-carbohydrate rat chow after exercise for 3-4 hours, the increased 
AS160 phosphorylation seen at either 3-4 hours or 27 hours post-exercise time-points 
was reversed to levels found in sedentary controls, concomitant with reversal of the post-
exercise increase in insulin-stimulated glucose transport (61).   
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 In summary, while much has been discovered about the conditions that lead to the 
sustained increase in insulin-stimulated glucose transport following exercise, the specific 
mechanisms involved in this action are unclear and extremely complex.  The increased 
insulin sensitivity that results occurs in the absence of increases in upstream insulin-
signaling.  Recent studies have found that AS160 phosphorylation is sustained after 
exercise and implicated this persistent effect as a possible contributor to the improved 
insulin sensitivity after a single bout of exercise. 
 
Protein Kinases that Regulate AS160 Phosphorylation 
 AS160 was originally identified as an Akt substrate, but subsequent studies have 
demonstrated that it is also a substrate for several other kinases, including AMPK, RSK, 
and SGK (Figure 2.4).  Bruss et al. (18) found that incubation of isolated rat 
epitrochlearis muscle with the AMPK-activator AICAR caused an increase in PAS-
AS160.  Since AICAR did not affect Akt phosphorylation, this result suggested that 
AMPK leads (directly or indirectly through other kinases) to an increase in PAS-AS160.  
The idea that AMPK acts directly on AS160 is supported by the observation that 
recombinant AMPK can PAS-phosphorylate AS160 in a cell-free assay (162).    
RSK has been shown to be activated by mechanical stress and by muscle 
contraction (104, 137).  SGK’s role in exercise has not yet been established.  However, 
SGK is activated by insulin and growth factors via PI3K, 3-phosphoinositide dependent 
kinase PDK1 and mTOR (100, 101, 127).  Both RSK and SGK have been shown to 
phosphorylate AS160 at Ser318, Ser588, and Thr642 in cell-free assays (64). The protein 
kinase p70S6K is a candidate to participate in the regulation of exercise-induced AS160 
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phosphorylation on the basis of the similarity of its consensus motif for substrates 
(p70S6K on Thr642 and Ser588 based on p70S6K’s similarity to RSK and SGK 
consensus motifs (64, 128). In addition, exercise can activate p70S6K in skeletal muscle 
(7, 32).  However, the ability p70S6K to phosphorylate AS160 remains to be 
demonstrated.  Furthermore, their activation several hours after exercise has not 
previously been evaluated concomitant with the determination of insulin-stimulated 
glucose transport. 
 
Protein Phosphatases that Regulate AS160 Phosphorylation 
Although four protein kinases that can phosphorylate AS160 are known, to date, 
none of the phosphatases that dephosphorylate AS160 have been identified.  In contrast 
to the hundreds of genes that encode protein kinases, there are far fewer that encode the 
various catalytic subunits of protein phosphatases (34).  Therefore, the functional 
diversity of serine/threonine protein phosphatases may lie in mechanisms that affect the 
formation of a large number of regulatory subunits that could affect the substrate 
specificity and subcellular localization of the phosphatases (35).  
Protein phosphatases have classically been categorized based on inhibition studies 
and were often studied with the use of phosphatase inhibitors that either selectively or 
indiscriminately target the various classes of phosphatases. Using this system, there are 
two major types of protein serine/threonine phosphatases: type-1 protein phosphatases 
(PP1) and type-2 protein phosphatases (PP2) (88, 147).  Continued research led to the 
discovery of diverse PP2 proteins and was therefore further divided into subgroups based 
on unique inhibitors selectively altering their activity: PP2A, PP2B, and PP2C.  
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Molecular cloning of mammalian phosphatase catalytic subunits further expanded the list 
of phosphatases to include PP2A-like phosphatases (PP3, PP4, PP5, and PP6) that share a 
conserved catalytic site and common inhibitors can alter activity of these phosphatases.  
An additional phosphatase that was discovered, PP7, has been shown to be insensitive to 
the known phosphatase inhibitors of PP2A and PP2B, similar to PP2C.  Based on much 
of the work accomplished using inhibitors, it is estimated that PP1 and PP2A account for 
over 90% of the serine/threonine protein phosphatases activity (171).     
With the advent of genome sequencing, classification of protein phosphatases has 
evolved.  Protein phosphatases are now broadly defined by their ability to 
dephosphorylate either tyrosine residues, Tyr phosphatases, or by their ability to 
dephosphoyrlate serine/threonine residues, Ser/Thr phosphatases.  Furthermore, Ser/Thr 
phosphatases can be organized into three major families: phosphoprotein phosphatases 
(PPPs), metal-dependent protein phosphatases (PPMs), and aspartate-based phosphatases 
(148).  PPPs include protein phosphatases 1 (PP1), PP2A, PP2B (also known as 
calcineurin), PP4, PP5, PP6, and PP7 (148).  PPMs include phosphatases dependent on 
manganese or magnesium ions (Mn2+/Mg2+), such as PP2C and pyruvate dehydrogenase 
kinase (148).  PPPs also have regulatory domains whereas PPMs do not.  Finally, PP1 
and PP2A content are nearly equivalent in most tissues, only skeletal muscle appears to 
have a disproportionately greater amount of PP1 compared to PP2A (171). 
PP1 
PP1 is a dimer protein consisting of a catalytic and regulatory subunit.  There are 
four known isoforms of the catalytic subunit (alpha, beta, gamma, and delta) and at least 
100 known regulatory subunits (120).  PP1 activity is regulated by many different 
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endogenous inhibitory proteins such as inhibitor-1 (126), inhibitor-2 (57), CPI-17 (53), 
and DARPP-32 (125, 167).  Relatively high concentrations of fostriecin (>100µM) and 
okadaic acid (>10nM) have been shown to inhibit PP1, but these concentrations also 
inhibit PP2A and PP2A-like phosphatases (33).  
PP2A 
 PP2A is a heterotrimer consisting of a catalytic, scaffolding, and regulatory 
subunit.  The role(s) of each subunit is incompletely understood.  There are two isoforms 
for each of the catalytic (alpha and beta) and scaffolding (alpha and beta) subunits.  There 
are four families of the regulatory subunit (B, B’, B’’, and B’’’) and each of these 
families have different isoforms with some of these isoforms containing splice variants 
(93).  The activity of the catalytic subunit (both isoforms) is regulated by post-
translational modifications via tyrosine phosphorylation of the 307 site and methylation 
of the 309 site (55, 184).  Additionally, methylation of the 309 site has been shown to 
preferentially allow the association of particular regulatory subunits (19, 45, 121, 184).   
PP2B/Calcineurin 
 Calcineurin is a heterodimer consisting of a catalytic and a regulatory subunit.  
Calcineurin is inactive alone and acquires phosphatase activity upon association with 
calcium-calmodulin binding (49).  Calcineurin appears to recognize substrate proteins 
(including NFAT) on a consensus recognition motif (20, 38, 135).  Cyclosporin A and 
FK506 are known specific inhibitors and do not target other phosphatases including 
PP2A-like phosphatases and PP2C (171).  EGTA, a calcium chelator, also inhibits 
calcineurin activity by virtue of inhibiting calcium-calmodulin binding (171). 
PP2C 
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 PP2C, unlike PP1, PP2A, and PP2B, is a monomeric protein that is a manganese 
and/or magnesium-dependent protein phosphatase.  There are 16 distinct genes in the 
human genome coding for 22 different isoforms of PP2C (107).  PP2C is insensitive to 
the inhibitors of PP2A and PP2B and much of the available research seeking to inhibit 
PP2C involves using gene-targeting such as siRNA (108).  The two most highly 
expressed isoforms, alpha and beta, are both expressed in skeletal muscle (115, 116).  
Several lines of evidence implicate PP2C as a phosphatase of AMPK (44, 113, 119, 142, 
153).   
 
Rationale for Models Used in this Research 
 Two rodent species (mice and rats) were used in the proposed research.  A large 
body of research has used rats to examine the post-exercise increase in insulin-stimulated 
glucose uptake.  Previous research using rats has characterized: 1) the post-exercise 
increase in insulin-stimulated GLUT4 translocation (72), 2) the time-course for the post-
exercise increase in insulin-stimulated glucose transport (27, 134), 3) the insulin-dose 
response for the post-exercise increase in insulin-stimulated glucose transport (63, 69, 91, 
134), 4) the lack of increased proximal insulin signaling post-exercise (56, 72, 160, 186), 
5) an increased AS160 phosphorylation in skeletal muscle post-exercise (5), and 6) the 
time-course for AS160 phosphorylation in skeletal muscle post-exercise (5). 
The genetic rat model that will be used in Study 2 is the Brown Norway Katholiek 
(BNK) rat.  These rats are plasma kininogen-deficient rats because of a spontaneous point 
mutation in the kininogen gene that causes serum kininogen deficiency by interfering 
with secretion of the liver synthesized kininogen (39-42).  BNK rats compared to Brown 
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Norway (BN) control rats have been reported to have moderate in vivo insulin resistance 
during a hyperinsulinemic-euglycemic clamp and fasting normoglycemia (41).   
 The genetic mouse model used in Study 1 was the B2 receptor of bradykinin 
knockout (B2RKO) mouse.  The B2RKO mice was compared to normal wildtype 
controls.  Using a hyperinsulinemic-euglycemic clamp, Duka et al. (51) reported a lower 
glucose infusion rate for B2RKO compared to WT mice, indicating that the B2RKO mice 
are more insulin resistant than WT mice.   
The number of publications discussing research using the mouse to study the post-
exercise increase in insulin-stimulated glucose uptake is much smaller than for rats.  
However, previous studies have evaluated the: 1) post-exercise increase in insulin-
stimulated glucose uptake (14, 16, 71), 2) insulin-dose response for glucose uptake (14, 
16, 71), and 3) Akt phosphorylation in skeletal muscle post-exercise (71). 
Insulin-stimulated glucose transport in rat skeletal muscle can be increased after 
in vivo exercise (27, 61, 72, 134, 169), in situ contractions (62, 97) and in vitro 
contractions performed in serum (52, 56, 58-60, 62).  Each of these models can provide 
useful information, but this proposal will exclusively use in vivo exercise which is 
relevant for translation to understanding how exercise benefits human health. 
Rationale for Exercise Protocols 
Swim exercise will be used in the rat experiments.  Swim exercise by rats has 
been well characterized as a model for studying the effects of the post-exercise increase 
in insulin-stimulated glucose transport.  Swimming exercise by rats has been shown to 
recruit the epitrochlearis muscle as evidenced by glycogen depletion, AMPK 
phosphorylation, insulin-independent glucose transport immediately after exercise, and 
25 
 
AS160 phosphorylation (immediately, 3 hours, and 27 hours after exercise) (5, 61, 158, 
168).  An advantage of swim exercise compared to treadmill running exercise in rats is 
that swimming does not require prior familiarization, whereas, treadmill exercise 
typically requires several familiarization sessions on at least two days prior to the 
terminal experiment.   
Treadmill exercise will be used in mouse experiments.  The protocol was 
developed as described in Hamada et al. and consists of 60 minutes of running (15–25 
m/min at 0% slope). This treadmill exercise has been shown to recruit the mouse soleus 
and EDL on the basis of glycogen depletion, increased AMPK phosphorylation, and 
increased insulin-independent glucose transport (71).  Bonen and colleagues (14, 16) 
showed increased glucose uptake in isolated mouse soleus muscle after acute treadmill 
running compared with sedentary controls.  Swim exercise will not be used for mice 
because a recent study reported that several different swim exercise protocols did not 
cause a subsequent increase insulin-stimulated glucose uptake in skeletal muscles 
(epitrochlearis, soleus, or EDL) from mice (96).  The explanation for these results is not 
obvious, but treadmill exercise compared to swim exercise appears to be a better model 
for studying post-exercise insulin sensitivity in mice. 
Rationale for Rodent Muscles to Be Used 
 For experiments using rats, the epitrochlearis muscle will be used.  The 
epitrochlearis muscle originates from the tendon of insertion of m. latissimus dorsi and 
inserting into the medial epicondyle of the humerus and functions to assist in the 
extension of the antebrachium (29).  It is innervated by the ulnar nerve and is supplied 
with blood via the muscular branch of a. profunda brachii (68).  The rat epitrochlearis is 
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very thin (only 21-24 fibers in thickness) (168), which allows for a small diffusion 
distance to maintain adequate and rapidly attained tissue levels of oxygen, nutrients, and 
3-O-methylglucose for muscle incubation and glucose transport measurement.  Long-
term incubation studies (30 hours) of epitrochlearis reveal no metabolic effects on ATP, 
PCr, glycogen, or lactate levels, indicative of adequate oxygenation and energy status of 
the muscles during incubation (168). The fiber type proportions of the rat epitrochlearis 
(75% Type IIb, 17% Type IIa, and 8% Type I) are very similar to the average fiber type 
composition of the 32 muscles of the rat hindlimb (76% Type IIb, 19% Type IIa, and 5% 
Type I) (6, 168). The epitrochlearis is also highly recruited during swim exercise based 
on glycogen depletion, AMPK phosphorylation and activation, and increased glucose 
transport after exercise compared to sedentary controls (5, 168).  Studies in rats have 
revealed that insulin stimulation and/or acute exercise does not result in a change in 
GLUT4 abundance, but rather in the cell-surface GLUT4 content.  Several hours after 
swim exercise by rats, there is no change in key proximal insulin signaling steps, but 
there is increased AS160 phosphorylation.   
 For experiments using mice, the soleus and extensor digitorum longus (EDL) 
muscles will be used.  The soleus and EDL are often used in incubation and glucose 
uptake studies (13, 16, 80, 87, 136, 138, 156, 178).  In mice, fiber type composition for 
soleus is reported to be 0% Type IIb, 39% Type IIa, and 61% Type I (43) and the EDL is 
reported to be 39% Type IIb, 60% Type IIa, and 1% Type I (31). The soleus and EDL are 
both recruited during treadmill exercise based on glycogen depletion, AMPK 
phosphorylation and activation, and increased insulin-independent glucose uptake after 
exercise compared to sedentary controls (71).   Treadmill exercise led to a significant 
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increase in glucose uptake of insulin-stimulated soleus muscle (71).  Bonen and 
coworkers have also found that prior treadmill exercise led to increased glucose uptake 
by isolated EDL and soleus muscles from mice (14, 16). 
  
 
Gaps to Be Filled by this Research 
 In the early 1980s Erik Richter and colleagues showed that exercise is followed 
by an increase in muscle insulin sensitivity (134).  While their observation has been 
confirmed in many previous studies in various species (including rats, mice, and humans) 
during the subsequent 30 years, the precise cellular mechanisms that are involved have 
not been fully elucidated.   
The KKS is activated by exercise, and its activation has been reported to favor 
improved insulin sensitivity.  Therefore, Studies 1 and 2 will explore the relationship 
between the KKS and the post-exercise increase in insulin-stimulated glucose transport.  
In Study 1, the necessity of the B2 receptor of bradykinin (B2R), an element of the KKS, 
to the post-exercise increase in insulin-stimulated glucose transport will be determined.   
Potential triggers leading to the increase in insulin-stimulated glucose transport that have 
not been evaluated with in vivo exercise are elements of the Kallikrein-Kininogen System 
(KKS) which can be modulated by exercise and which can enhance muscle glucose 
uptake under some conditions.   Earlier studies have shown that in vitro contraction 
performed in the presence of bradykinin did not lead to a subsequent increase in insulin-
stimulated glucose transport.  However, because bradykinin is degraded rapidly by 
kininases and recent evidence has suggested that increased skeletal muscle glucose 
uptake after in vitro contraction and in vivo exercise appear to occur through different 
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mechanisms, it would be useful to evaluate the role of the B2R with in vivo exercise.  
Accordingly, B2R knock-out mice will be compared to normal controls, to see if B2R is 
required for the post-exercise increase in insulin-stimulated glucose uptake.   In Study 2, 
the necessity of normal amounts of plasma kininogen, an element of the KKS that is the 
precursor for bradykinin formation during exercise, for the post-exercise increase in 
insulin-stimulated glucose transport will be determined.  Therefore, rats with a 
spontaneous mutation of the kininogen gene leading to plasma kininogen deficiency will 
be compared to normal rats to assess if, upon exercise, plasma kininogen is essential for 
the post-exercise increase in insulin-stimulated glucose transport.   
 In Study 3, the post-exercise activation states of muscle protein kinases and 
phosphatases that may contribute to the long-lasting increase in AS160 phosphorylation 
after exercise will be studied.  The increase in insulin-stimulated glucose transport after 
acute exercise occurs without enhanced upstream insulin signaling.  However, elevated 
AS160 phosphorylation in skeletal muscle is sustained up to 27 hours after exercise and 
this increase appears to track with the increased insulin sensitivity.  AS160 is an 
attractive target to study its involvement in enhanced insulin action, and presumably, 
sustained AS160 phosphorylation would result from sustained kinase signaling and/or 
phosphatase inhibition.  However, the kinases and phosphatases involved in sustained 
AS160 phosphorylation after exercise are unknown.  Therefore, to understand the events 
leading to sustained post-exercise AS160 phosphorylation, this study will determine: 1) if 
known kinases of AS160 are activated concomitant with prolonged phosphorylation of 
AS160 after exercise, 2) what protein phosphatases (PP1, PP2A, PP2B, and/or PP2C) can 
dephosphorylate phosphorylated AS160 from rat skeletal muscle stimulated with insulin 
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under cell-free conditions,  3) if phosphatases co-immunoprecipitate (PP1, PP2A, PP2B, 
and/or PP2C) with AS160, and 4) if exercise alters co-immunoprecipitation of 
phosphatases (PP1, PP2A, PP2B, and/or PP2C) with AS160 from rat skeletal muscle 
three hours after an acute bout of exercise. 
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Figure 2.1   
Insulin Signaling Cascade.  Insulin binding to its receptor triggers a downstream 
signaling cascade through insulin receptor substrate (IRS), phosphatidylinsolitol 3-kinase 
(PI3K), phosphatidylinsolitol-(3,4,5)- trisphosphate (PIP3), phosphoinositide-dependent 
kinase-1 (PDK1), mammalian target of rapamycin complex-2 (mTORC2) and Akt.  Akt 
phosphorylates AS160 on multiple sites, including Thr642 and Ser588 and, coincident 
with binding to 14-3-3 protein, leading to inhibition of AS160’s RabGAP activity and 
allowing subsequent Rab-dependent GLUT4 translocation to the cell-surface membrane 
from GLUT Storage Vesicles (GSV).  There is also evidence that insulin can increase 
GLUT4 translocation by AS160-independent mechanisms (e.g., by Akt’s 
phosphorylation of other substrates, depicted by the question mark). 
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Figure 2.2 
The Kallikrein-Kininogen System (KKS).  Kallikrein is a plasma enzyme that, when 
activated, cleaves the nine amino acid peptide bradykinin from kininogen, another plasma 
protein.  Bradykinin binds to the Bradykinin-2 Receptor (BK2) which is expressed by 
skeletal muscle cells.  Previous evidence has implicated bradykinin action on its receptor 
as being able to improve insulin sensitivity.  However, a role of the KKS in the post-
exercise insulin sensitivity has not been established.   
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Figure 2.3  
Proposed Role of Sustained AS160 Phosphorylation in the Post-Exercise Increase in 
Insulin-stimulated Glucose Transport.  The post-exercise increase in insulin-stimulated 
glucose transport occurs as a result of a post-exercise increase in insulin-stimulated 
GLUT4 translocation.  However, proximal insulin signaling steps (IR binding, pIR, IRTK, 
pIRS, IRS-PI3K, pAkt) that lead to insulin-stimulated GLUT4 translocation are not 
enhanced by prior exercise.  In contrast, AS160 phosphorylation at Thr642 (pT642) in 
exercised rats remains elevated above sedentary controls 4 hours post-exercise.  It seems 
conceivable that the sustained increase in AS160 phosphorylation at Thr642 (and 
possibly also Ser588) post-exercise plays a role in post-exercise increase in insulin-
stimulated glucose transport.  (Figure is modified from Cartee and Funai Exercise and 
Sport Sciences Reviews 37: 188-95, 2009.) 
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Figure 2.4  
Kinases and Phosphatases Proposed to Potentially Regulate AS160 Phosphorylation 
at Thr642 and Ser588.  The figure includes 5 possible kinases of AS160.  Akt and 
AMPK (solid arrow) have been supported by multiple lines of evidence to be 
physiologically relevant AS160 kinases in skeletal muscle. RSK and SGK (dashed arrow) 
can phosphorylate AS160 in a cell-free assay, but neither has been tested using more 
physiological approaches.  The consensus motif of p70S6K (dotted arrow) are similar to 
AS160’s Thr642 and Ser588 sites, but there is no direct evidence regarding whether 
p70S6K is a physiologically relevant AS160 kinase.  Exercise has been shown to activate 
4 of the 5 kinases (only SGK has not yet been evaluated post-exercise).  AS160 
phosphatases have not been evaluated, but PP1, PP2A, PP2B, and PP2C are Ser/Thr 
protein phosphatases that are highly expressed by rat skeletal muscle.   
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CHAPTER III 
 
STUDY 1 
 
The B2 receptor of Bradykinin is Not Essential for the Post-exercise Increase in 
Glucose Uptake by Insulin-stimulated Mouse Skeletal Muscle 
 
ABSTRACT 
Bradykinin can enhance skeletal muscle glucose uptake (GU), and exercise 
increases both bradykinin production and muscle insulin sensitivity, but bradykinin’s 
relationship with post-exercise insulin action is uncertain. Our primary aim was to 
determine if the B2 receptor of bradykinin (B2R) is essential for the post-exercise 
increase in GU by insulin-stimulated mouse soleus and extensor digitorum longus (EDL) 
muscles. Wildtype (WT) and B2R knockout (B2RKO) mice were sedentary or performed 
60 minutes of treadmill exercise that has been shown to increase glucose uptake in the 
insulin-stimulated soleus. Two experiments were conducted.  For Experiment 1, paired 
soleus muscles were excised from WT and B2RKO mice (SED or EX) and incubated 
with [3H]-2-deoxyglucose in the absence or presence of submaximally effective insulin 
(60μU/ml) to measure glucose uptake.  For Experiment 2, paired soleus and EDL muscles 
were excised and incubated with [3H]-2-deoxyglucose in the absence or presence of 
submaximally effective insulin (100μU/ml) and were used for measurement of glucose 
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uptake and Akt threonine phosphorylation (pThrAkt).  In each experiment, glucose 
uptake was measured approximately 70-90 minutes after exercise.  Data were analyzed 
by two-way ANOVA.  GU tended to be greater for WT vs. B2RKO soleus with 
60μU/mL insulin (P=0.166) and was significantly greater for soleus muscles with 
100μU/mL insulin (P<0.05), but there was no difference in GU in the EDL.  Both 
genotypes had significant exercise-induced reductions (P<0.05) in glycemia and 
insulinemia, and the decrements for glucose (~14%) and insulin (~55%) were similar 
between genotypes. GU tended to be greater for exercised vs. sedentary soleus with 
60μU/mL insulin (P=0.063) and was significantly greater for muscles with 100μU/mL 
insulin (P<0.05). There was no significant effect of exercise on glucose uptake by the 
EDL, with or without insulin, in either muscle. There were no significant interactions 
between genotype and exercise for blood glucose, plasma insulin or GU.  There were also 
no significant effects (exercise, genotype or interaction) on pThrAkt in either muscle, 
regardless of insulin concentration.  These results indicate that the B2R is not essential 
for the exercise-induced decrements in blood glucose or plasma insulin or for the post-
exercise increase in GU by insulin-stimulated mouse soleus muscle. 
 
INTRODUCTION 
A single exercise bout can lead to subsequently improved whole body insulin 
sensitivity, and skeletal muscle is the major tissue that accounts for this exercise-induced 
improvement in glucose disposal (22, 37). The increased glucose uptake by muscle is 
evident several hours after exercise cessation in vivo (38), and persists when rodent 
skeletal muscles are dissected out after exercise and studied in vitro (8, 9, 21).  
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The mechanisms whereby prior exercise initiates the improvement in skeletal 
muscle insulin sensitivity remain incompletely understood. Presumably, events that occur 
during exercise trigger the processes that subsequently lead to increased insulin-
stimulated glucose transport. Exercise induces increased production of a circulating 
nonapeptide bradykinin (2, 3, 34, 42, 43). Bradykinin can favor a subsequent increase in 
insulin-stimulated glucose uptake (1, 15, 23-26, 35). These observations raised the 
possibility that bradykinin may participate in the post-exercise increase in skeletal muscle 
insulin sensitivity. 
Skeletal muscle cells express the B2 receptor of bradykinin, B2R (14, 18, 36), 
which is important for bradykinin's influence on glucose uptake (1, 15, 18, 20). We 
studied mice that were null for B2R (B2 receptor of bradykinin knockout, B2RKO) and 
normal, wildtype (WT) mice under sedentary and post-exercise conditions to test the 
hypothesis that the B2R is essential for the post-exercise increase in glucose uptake by 
insulin-stimulated skeletal muscle.  
 
METHODS 
Materials.  Human recombinant insulin was from Eli Lilly (Indianapolis, IN). 2-
Deoxy-[3H]glucose and [14C]mannitol were from Perkin-Elmer (Boston, MA). Reagents 
and apparatus for SDS-PAGE, nonfat dry milk, and nitrocellulose membranes were from 
Bio-Rad Laboratories (Hercules, CA). A bicinchoninic acid assay kit for total protein 
determination and SuperSignal WestDura Extended Duration Substrate for 
immunodetection were from Pierce Biotechnology (Rockford, IL). Anti-phospho-Akt 
Thr308 and secondary antibody (horseradish peroxidase-conjugated anti-rabbit IgG) was 
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from Cell Signaling Technology. Other reagents were from Sigma-Aldrich (St. Louis, 
MO). 
Animals.  Animal care was approved by the University of Michigan Committee 
on Use and Care for Animals. Male mice null for the B2 receptor of bradykinin (B2RKO; 
strain 002641) and wildtype (WT) control mice (strain 101045; B6129SF2/J) were from 
the Jackson Laboratory (Bar Harbor, ME). All mice were housed in plastic cages and 
provided a standard diet (Lab Diet, PMI Nutrition International, Richmond, IN) and water 
ad libitum.  
Treadmill exercise protocol.  All mice (8–18 wk old) were familiarized with 
treadmill (Columbus Instruments, Columbus, OH) running for 10min on 2 consecutive 
days (1st day at 12–22m/min; 2nd day at 12–25 m/min). On the morning after the 2nd 
familiarization day, the WT and B2RKO mice were assigned to either a sedentary or 
exercised group. The exercise protocol consisted of 3 consecutive 20min-periods of 
progressive interval exercise (5min at 15m/min, 10min at 20m/min, and 5min at 25m/min 
with 0% slope) totaling 60min of running (21). Access to food was removed for all mice 
at the time that the protocol began. The approximate percentages of maximum O2 uptake 
required for untrained mice running at the speeds used in this exercise protocol, based on 
the prediction equation of Fernando et al. (17), would be expected to be 80% at 15 
m/min, 86% at 20 m/min, and 91% at 25 m/min. All of the exercised mice completed 
the 60min protocol, after which exercised and sedentary mice were immediately 
anesthetized (intraperitoneal injection of pentobarbital sodium, 50mg/kg body wt) and 
rapidly dissected for muscle incubation.  Therefore, glucose uptake was measured 
approximately 70-90 minutes after completion of exercise bout. 
51 
 
Blood glucose and plasma insulin. Blood was collected from the tail using 
heparinized capillary tubes, prior to anesthetization, in sedentary mice and in exercise 
mice immediately following the 60min treadmill protocol.  Blood glucose was 
determined using an Accu-Check® Aviva (Roche Diagnostics, Indianapolis, IN) hand-
held blood glucose meter. Blood was transferred to microcentrifuge tubes, centrifuged, 
and the plasma collected was used to assay insulin with the ALPCO DiagnosticsTM 
Insulin (Mouse) Ultrasensitive EIA kit, catalog no. 80-INSMSU-E01 (Alpco Diagostics, 
Salem, NH). 
Tissue dissection and muscle incubation.  Paired soleus (Experiments 1 and 2) and 
extensor digitorum longus (EDL; Experiment 2) muscles from anesthetized mice were 
excised and incubated using a 2-step incubation protocol. During the 1st step, muscles 
were placed in vials containing 1.5mL of Krebs-Henseleit Buffer (KHB) supplemented 
with 0.1% bovine serum albumin (BSA), 2mM sodium pyruvate, and 6mM mannitol in 
the absence or presence of insulin (60μU/mL insulin was used for mice in Experiment 1; 
100μU/mL insulin was used for mice in Experiment 2) for 60min.  During all incubation 
steps, vials were placed in a heated (35°C), shaking water bath and continuously gassed 
from above (95% O2-5% CO2).  
After the 1st incubation step, muscles were transferred to a 2nd vial containing 
KHB with 0.1% BSA, 1mM 2-deoxyglucose (2-deoxy-[3H]glucose, 6 mCi/mmol), 9mM 
mannitol ([14C]mannitol, 0.053 mCi/mmol), and the same insulin concentration as the 
previous step. Muscles were incubated at 35°C for 15min and then rapidly blotted on ice-
cold filter paper, trimmed, freeze clamped, and stored at –80°C until processed. 
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Epididymal fat pads and gastrocnemius muscles were removed from some mice 
and weighed. 
Muscle homogenization.  Frozen muscles were weighed, transferred to prechilled 
glass tubes and homogenized in: 1) 0.5ml of perchloric acid (muscles from Experiment 1) 
or 2) ice-cold lysis buffer (0.5mL) containing 20mM Tris-HCl, 150mM NaCl, 1% NP-40, 
1mM activated Na3VO4, 2mM EDTA, 2mM EGTA, 2.5mM sodium pyrophosphate, 
1mM β-glycerophosphate, 1μg/ml leupeptin (muscles from Experiment 2).  Lysis buffer 
was used for the muscles analyzed for both glucose uptake and immunoblotting. Samples 
homogenized in perchloric acid were centrifuged (15,000g, 15min), and samples 
homogenized in the lysis buffer were rotated for ~1hr before being centrifuged (15,000g, 
15min). Aliquots from supernatants were quantified for [3H] and [14C] using a liquid 
scintillation counter, and glucose uptake was calculated (7).   
Immunoblotting.  Portions of samples processed in lysis buffer were analyzed by 
immunoblotting for phospho-Akt Thr308.  Total protein concentration of the supernatants 
used for immunoblotting was determined by the bicinchoninic acid assay (41). Samples 
were resolved on a 10% SDS-PAGE gel and transferred to nitrocellulose in electrotransfer 
buffer overnight at 4°C. Blots were incubated in blocking solution [Tris-buffered saline 
(TBS) with 0.1% Tween 20 (TBST) and 5% nonfat dry milk] for 1hr at room 
temperature, washed with TBST and then incubated with anti-phospho-Akt Thr308 
overnight at 4°C. Blots were washed with TBST and incubated with secondary antibody 
(horseradish peroxidase-conjugated anti-rabbit IgG). Blots were washed of excess 
antibody with TBST and then subjected to SuperSignal enhanced chemiluminesence 
(Thermo Scientific, Rockford, IL). Immunoreactive protein was quantified by 
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densitometry (Alpha Innotech, San Leandro, CA). The mean value for WT sedentary 
samples on each immunoblot, expressed in densitometry units relative to total protein, 
was adjusted to equal 1.0. Each sample value was expressed relative to the adjusted mean 
value for the WT sedentary control. 
Statistical analyses.  Statistical analyses used Sigma Stat version 2.0 (San Rafael, 
CA). Data are expressed as means ± SE. Two-way ANOVA was used to determine 
significant differences, and a Tukey post hoc test was used to identify the source of 
significant variance. A P value ≤0.05 was considered statistically significant. 
 
RESULTS 
 There were no statistically significant interactions (exercise x genotype) for any 
of the measurements that were made. 
Body and tissue masses.  Body mass was similar between genotypes, but the 
epididymal fat pad/ body mass ratio was ~30-37% lower (P<0.001) for B2RKO 
compared to WT mice (Table 1). The soleus/body mass ratio was ~10% greater (P<0.05) 
and the EDL/body mass ratio was 15% greater (P<0.05) for B2RKO vs. WT mice, but 
there was not a significant effect of genotype on gastrocnemius/body mass ratio (Table 
1). 
Blood glucose and plasma insulin.  Glycemia was 14% greater in B2RKO vs. WT 
mice under both sedentary and exercised conditions (P<0.01; Table 1). Within each 
genotype, exercise caused a similar ~14% decrease in blood glucose (P<0.05). Plasma 
insulin was ~32% lower (P<0.05) in the B2RKO vs. WT mice in sedentary and exercised 
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conditions. In both genotypes, exercise caused a 55% decrease in plasma insulin 
(P<0.001). 
Muscle glucose uptake.  In the soleus (Fig. 3.1A and 3.1B) and EDL (Fig. 3.2), 
there was not an effect of genotype on glucose uptake without insulin in either 
experiment or when the data from both soleus experiments were pooled (data not shown). 
Soleus glucose uptake with insulin was lower for B2RKO vs. WT mice with 100µU/mL 
insulin (P<0.05), and a non-significant trend (P=0.166) for lower values in the B2RKO 
mice was also evident with 60µU/mL insulin. For the pooled data from the insulin-treated 
soleus, glucose uptake was significantly lower (P<0.05) in the B2RKO compared to WT 
mice. EDL glucose uptake with insulin was not different between genotypes.  Paired 
muscles were used for glucose uptake measurements, with one muscle from each mouse 
incubated without insulin and the contralateral muscle incubated with insulin. We 
calculated the insulin-stimulated increase in glucose uptake (delta insulin) by subtracting 
the basal value from the insulin-stimulated value. Soleus delta insulin was significantly 
lower for B2RKO vs. WT mice with 60µU/mL (P<0.05), 100µU/mL (P<0.05) and when 
the data from both experiments were pooled (P<0.001).  EDL delta insulin was not 
different between genotypes.   
Soleus glucose uptake without insulin tended to be slightly higher for exercised 
vs. sedentary mice in both Experiment 1 (P=0.090; Fig. 3.1A) and Experiment 2 
(P=0.087; Fig. 3.1B). The pooled values for soleus glucose uptake without insulin from 
both experiments were significantly greater for the exercised vs. sedentary (P<0.05). In 
the insulin-stimulated soleus, glucose uptake tended to be greater for the exercised vs. 
sedentary mice in Experiment 1 (P=0.063 with 60µU/ml; Fig. 3.1A) and was significantly 
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greater in Experiment 2 (P<0.05 with 100µU/ml; Fig. 3.1B). When data from both 
experiments were pooled, soleus glucose uptake of insulin-stimulated muscles was 
significantly greater (P<0.005) for exercised vs. sedentary mice. Soleus delta insulin 
tended to be greater for exercised vs. sedentary mice with 60µU/mL (P=0.150) or 
100µU/mL (P=0.094), and the delta insulin values were significantly greater after 
exercise when the data from both experiments were pooled (P<0.05).  
Glucose uptake by the EDL, determined only for Experiment 2, was not altered 
by exercise or genotype without or with 100µU/mL of insulin (Fig. 3.2). 
AktThr308 phosphorylation.  In both soleus (Fig 3.3) and EDL (Fig 3.4), there was a 
significant increase in AktThr308 phosphorylation when incubating muscles with insulin 
compared to incubating muscles without insulin.  Soleus (Fig. 3.3) and EDL AktThr308 
phosphorylation (Fig. 3.4) were not significantly altered by exercise or genotype, with or 
without insulin, or for delta insulin (Fig. 3.3).  
 
DISCUSSION 
Improved whole body insulin sensitivity is a hallmark-effect of prior exercise. A 
post-exercise elevation in insulin-stimulated glucose uptake by skeletal muscle has been 
found in humans (38, 46), rats (8, 9, 37), and mice (4, 5, 21). The primary aim of this 
study was to determine if the B2R is essential for the post-exercise increase in glucose 
uptake in insulin-stimulated skeletal muscle. Prior exercise resulted in an increased 
glucose uptake by soleus muscles incubated with 100µU/mL insulin and a trend 
(P=0.063) for increased glucose uptake by soleus muscles incubated with 60µU/mL 
insulin. The lack of a significant interaction between genotype and exercise on glucose 
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uptake by soleus muscles incubated with either insulin concentration indicates that the 
B2R is not essential for the post-exercise increase in glucose uptake.  There was not an 
exercise effect on glucose uptake by the isolated EDL.  Whereas earlier research has 
consistently indicated that treadmill exercise by mice can induce a subsequent increase in 
glucose uptake by the soleus, the results in the EDL have been more variable (4, 5, 21).  
The explanation for the apparently more robust exercise effect in soleus compared to 
EDL muscle of mice remains to be identified, e.g., whether it is related to fiber type (44), 
muscle recruitment (31), contractile properties (6), or something else.  This study focused 
on glucose uptake, which is a rate-controlling process for skeletal muscle glucose 
metabolism.  However, the current results do not eliminate the possibility that the B2R 
may influence other aspects of muscle metabolism, including glycogen synthesis, glucose 
oxidation, lipid synthesis, and fatty acid esterification that we did not assess. 
Earlier research demonstrated that circulating bradykinin can be increased by 
exercise or muscle contraction (2, 3, 34, 42, 43). Furthermore, there is substantial 
evidence that bradykinin can elevate glucose uptake in both intact animals (11, 15, 32, 
45) and isolated cells or tissues (1, 12, 26, 30, 33, 35). It seemed possible that bradykinin 
could be involved in the post-exercise increase in insulin-stimulated glucose transport. 
However, previous studies indicated that electrically stimulated contractions by isolated 
rat epitrochlearis in the presence of exogenous bradykinin did not cause a subsequent 
increase in glucose transport of insulin-stimulated muscles (16). Furthermore, HOE-140, 
a B2R inhibitor, did not reduce the ability of prior contraction in serum to increase 
insulin-dependent glucose transport (16). These results did not support a role for 
bradykinin in the post-contraction increase in insulin sensitivity, but because bradykinin 
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is very rapidly degraded by kininases, experiments using exogenous bradykinin should be 
interpreted cautiously. Accordingly, in the current study, we used in vivo exercise by 
mice lacking the B2R as a novel approach to assess bradykinin’s potential importance for 
the persistent increase in insulin-stimulated glucose uptake after in vivo exercise. The 
current results for in vivo exercise extend the earlier findings using exogenous bradykinin 
or B2 receptor inhibitors with ex vivo muscle contractions. These results using several 
different approaches do not support the idea that exercise or contraction lead to 
subsequent elevation in insulin sensitivity as the result of a B2R-dependent mechanism.  
The ~14% decline in blood glucose in both genotypes compares to an ~12-29% 
decrease in glycemia previously reported for normal mice after 60min of treadmill 
exercise (19, 28, 29, 47). Treadmill exercise caused an ~32% decline in plasma insulin 
concentration in both genotypes, which compares to published results indicating an ~33-
52% reduction in circulating insulin after 60min of treadmill exercise by normal mice 
(19, 21, 27, 28). The absence of significant exercise x genotype interactions in the current 
study suggests that the expression of the B2R was not essential for exercise effects on 
either glycemia or insulinemia. 
Glucose uptake by isolated soleus and EDL muscles in the absence of insulin was 
not different for B2RKO compared to WT mice. However, for soleus muscles with 
100µU/mL insulin there was a genotype-associated reduction in glucose uptake for 
B2RKO vs. WT mice, which was not seen in the EDL.  A previous study in mouse soleus 
and EDL muscle using HOE-140 with a maximal insulin challenge in vivo revealed a 
non-significant trend for a decrease in glucose uptake in the soleus, but not the EDL, in 
HOE-140 vs. saline injected mice (40).  There is evidence from experiments using either 
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a genetic or pharmacologic approach suggesting that the B2R may be more important for 
controlling the insulin-stimulated glucose uptake of the soleus versus the EDL, but the 
explanation for the difference between muscles is uncertain.   
The reduced glucose uptake seen in the soleus of B2RKO vs. WT mice are 
reminiscent of the previously reported results of a study using the euglycemic-
hyperinsulinemic-clamp in which Duka et al. (15) reported a lower glucose infusion rate 
for B2RKO compared to WT mice. Duka et al. (15) reported a non-significant trend for a 
13% increase in fasting glycemia for B2RKO vs. WT mice which corresponds to the 14% 
increase in blood glucose that we found in B2RKO mice. We found a lower value for 
plasma insulin concentration in the B2RKO vs. WT mice, whereas Duka et al. (15) did 
not find a significant difference between the genotypes for fasting insulin. Rather they 
found a non-significant trend for higher fasting insulin for B2RKO mice. The mice in the 
earlier study had been treated for 3 days prior to the clamp with captopril, an ACE 
inhibitor which also inhibits kininase II (the enzyme which degrades bradykinin). 
Furthermore, the mice in the current study were only fasted ~1hr prior to sampling 
plasma for the insulin assay. Duka et al. (15) did not explicitly describe the duration of 
the fast, but they cited the method used in an earlier euglycemic-hyperinsulinemic clamp 
study in which the animals underwent an overnight fast.  The age and sex of the mice in 
the earlier study were not described.  It is uncertain if these or other differences in 
experimental design account for the different effect of B2RKO on circulating insulin 
concentration.  The lower plasma insulin concentration for B2RKO vs. WT mice suggests 
that there may have been decreased insulin secretion in the B2RKO animals. 
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 The current study provides the first insulin signaling data for B2RKO mice. 
Muscle AktThr308 phosphorylation for the soleus and the EDL muscles was similar 
between B2RKO and WT mice implicating an Akt-independent mechanism for the 
insulin resistance found in the B2RKO soleus muscles. Muscle (soleus or EDL) AktThr308 
phosphorylation was also not different for exercised compared to sedentary groups, 
consistent with earlier data after exercise by normal mice (21) and providing evidence 
that the increased insulin sensitivity after exercise, regardless of B2R expression, does 
not require enhanced AktThr308 phosphorylation.  
The current results are consistent with previous studies (10, 39) in which body 
mass was not different between B2RKO and WT mice. Schanstra et al. (39) also found 
no difference between B2RKO and WT mice for food intake.  A more recent study 
reported that B2RKO vs. WT mice had greater energy intake and energy expenditure 
concomitant with a ~25% reduction in total body fat content (per g body mass) 
determined by carcass analysis (13).  The results for lower body fat are similar to the 
reduction in epididymal fat pad/body mass ratio for the B2RKO compared to WT mice in 
the current study. They also found the gastrocnemius mass (per g body mass) of the 
B2RKO mice to be ~19% greater than control mice.  Although gastrocnemius mass was 
not significantly different between genotypes in the current study, the soleus/body mass 
ratio and the EDL/body mass ratio were greater for B2RKO versus WT mice.  The 
metabolic phenotype of B2RKO mice occurs despite moderate decrements in body fat 
and increments in skeletal muscle mass which are typically expected to favor improved 
insulin sensitivity.   
60 
 
 In conclusion, mice lacking the B2R compared to WT controls had a small 
reduction in glucose uptake by insulin-stimulated soleus muscles concomitant with an 
undiminished insulin-stimulated increase in Akt phosphorylation. Earlier in vivo results 
from B2RKO mice undergoing a hyperinsulinemic clamp demonstrated insulin 
resistance, but they had not directly evaluated skeletal muscle or assessed insulin 
signaling. The current results demonstrate that insulin resistance of the soleus muscles, 
but not the EDL muscles, lacking the B2R persists ex vivo and suggest this defect is 
secondary to an Akt-independent mechanism.  The explanation for genotype having 
different effects on insulin-stimulated glucose uptake in the soleus compared to the EDL 
is unknown.  The absence of the B2R also did not alter the effects of exercise on 
circulating glucose or insulin concentrations in vivo indicating that the B2R is not a major 
modulator of the important effects of acute exercise on either glycemia or insulinemia. 
Finally, the lack of a significant interaction between exercise and genotype for glucose 
uptake by insulin-stimulated skeletal muscle after exercise demonstrates that the B2R is 
not essential for the increased glucose uptake in insulin-stimulated soleus muscles after 
exercise by mice.   
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 WT 
Sedentary 
WT 
Exercise 
B2RKO 
Sedentary 
B2RKO 
Exercise 
Body mass, g 26.4±0.6 26.3±0.7 26.8±0.5 26.4±0.6 
Fat pad/body mass ratio  
   (mg/g) 
6.5±0.4 7.0±0.4 4.6±0.3* 4.4±0.3* 
Soleus/body mass ratio     
   (mg/g) 
EDL/body mass ratio  
   (mg/g) 
Gastrocnemius/body mass  
   ratio (mg/g) 
Blood glucose, mmol·L-1 
0.36±0.02 
 
0.37±0.02 
 
4.7±0.1 
 
7.85±0.51 
0.34±0.1 
 
0.39±0.01 
 
4.7±0.1 
 
6.74±0.48† 
0.39±0.2* 
 
0.45±0.02* 
 
4.9±0.3 
 
8.91±0.25* 
0.38±0.2* 
 
0.45±0.02* 
 
5.0±0.1 
 
7.65±0.31†* 
Plasma insulin, ng·mL-1 0.673±0.12 0.307±0.06† 0.455±.06* 0.205±.04†* 
 
Table 3.1  
Body mass and tissue/body mass ratios and glucose and insulin concentrations.  
Values are means ± SE, n = 21-22 for body mass; n = 21-22 for soleus/body mass ratio; n 
= 16 for EDL/body mass ratio; n = 8 for gastrocnemius/body mass ratio; and n= 14-16 for 
epididymal fat pad/body mass ratio and glucose and insulin concentrations. *P<0.05 
(WT vs. B2RKO). †P<0.05 (Sedentary vs. Exercise). 
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Figure 3.1  
Glucose uptake by isolated soleus muscles. Experiment 1: without or with 60μU/mL 
insulin (A); Experiment 2: without or with 100μU/mL insulin (B) from WT and B2RKO 
mice that were sedentary (SED) or exercised (EX).   Insets of (A) and (B) represent the 
insulin-stimulated increase in glucose uptake (delta insulin) calculated by subtracting the 
basal value from the insulin-stimulated value of paired muscles. Values are mean ± SE 
for 9 or 15-16 muscles per group (A and B, respectively). P<0.05. E, main effect of 
exercise treatment; G, main effect of genotype; E x G, interaction between main effects. 
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Figure 3.2  
Glucose uptake by isolated extensor digitorum longus (EDL) muscles. Glucose 
uptake by isolated EDL muscles (Experiment 2) without or with 100μU/mL insulin (B) 
from WT and B2RKO mice that were sedentary (SED) or exercised (EX).   Inset 
represents the insulin-stimulated increase in glucose uptake (delta insulin) calculated by 
subtracting the basal value from the insulin-stimulated value of paired muscles. Values 
are mean ± SE for 15-16 muscles per group. P<0.05. E, main effect of exercise 
treatment; G, main effect of genotype; E x G, interaction between main effects. 
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Figure 3.3  
AktThr308 phosphorylation in isolated soleus. AktThr308 phosphorylation in isolated 
soleus from WT and B2RKO mice that were SED or EX.  The insets represents the 
insulin-stimulated increase AktThr308 (delta insulin) calculated by subtracting the basal 
value from the insulin-stimulated value of paired muscles. Values are mean ± SE for 8 
muscles per group.  
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Figure 3.4  
AktThr308 phosphorylation in isolated EDL. AktThr308 phosphorylation in isolated EDL 
from WT and B2RKO mice that were SED or EX.  The insets represents the insulin-
stimulated increase AktThr308 (delta insulin) calculated by subtracting the basal value from 
the insulin-stimulated value of paired muscles. Values are mean ± SE for 8 muscles per 
group.  
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CHAPTER IV 
 
STUDY 2 
 
Post-exercise Skeletal Muscle Glucose Transport is Undiminished in Kininogen-
Deficient Rats 
 
ABSTRACT 
A single exercise bout stimulates skeletal muscle glucose transport (GT) in the absence or 
presence of insulin. It has been suggested that the Kallikrein-Kininogen System (KKS) 
may contribute to exercise effects on both insulin-independent and insulin-dependent 
glucose transport.  Plasma kininogen, a key KKS component, is a protein substrate for the 
enzyme kallikrein and the source of the peptide bradykinin.  The purpose of the study 
was to determine if the post-exercise (PEX) increase in insulin-dependent or insulin-
independent GT is reduced in rats deficient in plasma kininogen vs. normal rats.  Male 
Brown Norway (BN) and Brown Norway Katholiek (BNK; plasma kininogen deficient) 
rats were studied.  BN and BNK rats were assigned to exercise (4 x 30 minute swim) or 
sedentary (SED) groups.  Rats were anesthetized immediately (0hPEX) or 3 hours 
(3hPEX) after exercise.  For 0hPEX and 0hSED rats, one epitrochlearis muscle per rat 
was used for AMPK phosphorylation and muscle glycogen analyses.  The contralateral 
muscle was incubated with [3H]-3-O-methylglucose (3MG) for GT assay.   For 3hPEX 
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and 3hSED rats, one muscle from each rat was incubated without insulin, and the 
contralateral muscle was incubated with 60µU/ml insulin and both muscles were 
incubated with 3MG for GT measurement.  For 0hPEX vs. 0hSED, both BN and BNK 
rats had greater insulin-independent GT and AMPK phosphorylation with reduced 
glycogen.  No genotype effects were found 0hPEX. There was a significant main effect 
of exercise (3hPEX > 3hSED) and no interaction between exercise and genotype for 
basal or insulin-stimulated GT.  Plasma kininogen deficiency did not alter insulin-
independent GT, AMPK phosphorylation or glycogen depletion 0hPEX or insulin-
dependent GT 3hPEX suggesting that normal plasma kininogen is not essential for these 
important exercise effects.  
 
INTRODUCTION 
Skeletal muscle glucose transport is stimulated both by insulin and exercise.  A 
single exercise session can stimulate glucose transport  in the absence of insulin (insulin-
independent), and  it can also increase insulin’s ability to increase glucose transport 
(insulin-dependent) (9, 10, 12, 43, 45, 53).  Most of the insulin independent effect is lost 
~3 hours post-exercise in rat muscle, at which time glucose transport in the presence of 
physiological insulin concentration is elevated, i.e., insulin sensitivity is increased (9, 10, 
45, 53).  
The mechanisms leading to the increased insulin-independent glucose transport 
immediately after exercise and increased insulin-dependent glucose transport several 
hours after exercise are not fully understood.  Several lines of evidence have led to the 
proposal that the Kallikrein-Kininogen System (KKS) might play a role in the effects of 
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exercise on skeletal muscle glucose transport (19, 33, 50).  Exercise or skeletal muscle 
contraction can activate the KKS as evidenced by increased circulating levels of 
bradykinin, a nonapeptide that is produced as the result of the interaction between two 
plasma proteins (kallikrein and kininogen) which are essential elements of the KKS (4, 
35, 49).  Exercise has been shown to increase the activity of kallikrein (52), the enzyme 
which catalyzes the proteolytic cleavage of bradykinin from plasma kininogen (3).  
Bradykinin binding to the B2 receptor of bradykinin has been implicated as a mediator of 
increased glucose transport and improved insulin sensitivity (11, 20, 27-29, 34, 38).  
Gao et al. (24) demonstrated that electrically stimulated contraction by isolated rat 
epitrochlearis muscle in the presence of serum, but not in the absence of serum, can lead 
to a subsequent improvement in insulin sensitivity.  They also provided convincing 
evidence that the enhanced insulin-stimulated glucose transport in this model requires the 
presence of a serum protein with a molecular mass greater than 10 kDa.  The molecular 
masses of kallikrein and kininogen are greater than 10 kDa, raising the possibility that 
KKS proteins might be required for the post-contraction increase in glucose transport.  
Dumke et al. (21) found that muscles stimulated to contract in kallikrein-deficient plasma 
compared to muscles that performed contractions in normal plasma had reduced insulin-
stimulated glucose transport.  Although electrically stimulated contraction is a valuable 
model, it is not a perfect replica of in vivo exercise.  Accordingly, we used in vivo 
exercise for the current study. 
Brown Norway Katholiek (BNK) rats have a spontaneous point mutation in the 
kininogen gene which causes circulating kininogen deficiency by interfering with 
secretion of the liver synthesized kininogen (14-17).  Plasma kininogen values of BNK 
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rats have been reported to be less than 1% of the normal plasma values for Brown 
Norway (BN) rats (41).  Urinary kinin release is readily measured in normal rats and 
barely detectable in BNK rats (36, 37, 39). BNK rats have also been reported to have 
moderate in vivo insulin resistance and fasting normoglycemia compared to BN rats (16).  
The primary hypothesis tested by this study was that BNK compared to BN rats are 
characterized by a reduction in post-exercise insulin-stimulated glucose transport.  It has 
also been suggested that activation of the KKS may play a role in the exercise-induced 
increase in insulin-independent glucose transport (33, 50).  Therefore, a secondary aim 
was to compare the post-exercise increase in insulin-independent glucose transport in 
skeletal muscles from BN and BNK rats. 
 
METHODS  
Materials. Human recombinant insulin was obtained from Eli Lilly (Indianapolis, 
IN). Reagents and apparatus for SDS-PAGE and immunoblotting were purchased from 
Bio-Rad (Hercules, CA). Bicinchoninic acid protein assay reagent (no. 23227), T-PER 
tissue protein extraction reagent (no. 78510) and West Dura Extended Duration Substrate 
(no. 34075) were purchased from Pierce Biotechnology (Rockford, IL). Goat anti-rabbit 
IgG horseradish peroxidase conjugate (no. 7074) and Anti-phospho-Thr172 AMPKα 
(pAMPK-Thr172; no. 2531) were purchased from Cell Signaling Technology (Danvers, 
MA).  3-O-methyl-[ 3H]glucose ([3H]3-MG) was purchased from Sigma-Aldrich (St. 
Louis, MO). [14C]Mannitol was from PerkinElmer (Waltham, MA). Other reagents were 
purchased from Sigma-Aldrich and Fisher Scientific (Pittsburgh, PA). 
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Animal treatment. Procedures for animal care were approved by the University of 
Michigan Committee on Use and Care of Animals, and the experiments were performed 
under adherence to American College of Sports Medicine animal care standards. Male 
Brown Norway (BN) rats (7-10 wk-old; 160 ± 3g; Charles River Laboratories, 
Wilmington, MA) and male Brown Norway Katholiek (BNK) rats (7-10 wk-old; 168 ± 
8g; generously provided by Dr. Oscar Carretero) had ad libitum access to rodent chow 
(PMI Nutritional International, Brentwood, MO) and water until 1700 on the night before 
the experiments, when food was removed from their cages, and all of the rats remained 
fasted for the remainder of the study. On the following day, rats were randomly assigned 
to a post-exercise (PEX) or sedentary (SED) treatment. Beginning at ~0900, PEX rats 
swam in a barrel filled with water (35°C) to a depth of ~60 cm (7 or 8 rats/barrel) for 4 x 
30 minute bouts, with a 5 minute rest period between each bout.   
Experimental Design.  PEX rats of each genotype (BN and BNK) were studied 
either immediately after exercise (0hPEX; n=7 for BN and n=7 for BNK) or 3 hours after 
exercise (3hPEX; n=16 for BN and n=15 for BNK).  Sedentary rats remained in their 
cages while the PEX rats were swimming and were studied at times that matched either 
the 0hPEX group (0hSED;  n=8 for BN and n=8 for BNK) or the 3hPEX group (3hSED; 
n=15 for BN and n=15 for BNK).  
Muscle incubations. Rats were anesthetized with an intraperitoneal injection of 
pentobarbital sodium (5mg/100 g body wt) either immediately post-exercise (0hPEX) or 
3-4 hours post-exercise (3hPEX) along with time-matched sedentary rats.  For the 0hPEX 
experiment, following anesthetization, one epitrochlearis muscle from each rat was 
rapidly dissected out, trimmed, freeze-clamped using aluminum clamps cooled to the 
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temperature of liquid N2, and stored at -80°C until analyzed. After dissection, the 
contralateral muscle in the 0hPEX study was incubated for 10 minutes in flasks 
containing Krebs-Henseleit Buffer (KHB) with 0.1% bovine serum albumin (BSA), 2 
mM pyruvate, and 6 mM mannitol for 10 minutes.  The muscles were then transferred to 
flasks containing KHB, 0.1% BSA, 8 mM 3-MG (including 0.25 mCi/mmol [3H]3-MG), 
and 2 mM mannitol (including 0.1 mCi/mmol [14C]mannitol).  For both incubation steps, 
flasks were continuously gassed from above with 95% O2-5% CO2 and shaken in a 
heated water bath (30°C).  
For the 3hPEX experiment, rats were dried following the final exercise bout and 
returned to their cage for 3 hours before being anesthetized.  After anesthetization, both 
epitrochlearis muscles from each animal were dissected out. One muscle from each rat 
was incubated in KHB, 0.1% BSA, 8 mM glucose, 2 mM mannitol supplemented with 
60µU/ml insulin (a physiological concentration), and the contralateral muscle was 
incubated in the same solution without insulin.  Both muscles were incubated for 30 
minutes in a shaking water bath at 35°C. Insulin remained present at the same 
concentration throughout all subsequent incubations. After the initial incubation, muscles 
were transferred to vials containing KHB, 0.1% BSA, 2 mM pyruvate, and 6mM 
mannitol with or without 60µU/ml insulin at 30°C for 10 minutes. Finally, muscles were 
transferred to flasks containing KHB, 0.1% BSA with 8 mM 3-MG (including 0.25 
mCi/mmol [3H]3-MG), and 2 mM mannitol (including 0.1 mCi/mmol [14C]mannitol) 
with or without 60µU/ml insulin for determination of glucose transport rate. After 
incubation with 3-MG for 15 minutes, the muscles were rapidly blotted on filter paper 
dampened with incubation medium, trimmed, freeze-clamped, and stored at -80°C.  
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Homogenization, glucose transport measurement, and protein concentration 
determination. Frozen muscles used for glucose transport and immunoblotting (pAMPK-
Thr172) were homogenized in 1 ml ice-cold homogenization buffer (2 mM activated 
Na3VO4, 2 mM EDTA, 2 mM EGTA, 2.5 mM sodium pyrophosphate, 1 mM β-
glycerophosphate, 1 mM phenylmethanesulfonyl fluoride, and 1 µg/ml leupeptin in T-
PER) using tissue grinder tubes (Kontes, Vineland, NJ). Homogenates were subsequently 
rotated at 4°C at 50 rpm for 1 hour before being centrifuged (15,000 g for 15 minutes at 
4°C). Aliquots of the supernatant from muscles used for the 3-MG transport measurement 
were pipetted into vials with scintillation cocktail for scintillation counting, and 3-MG 
transport was determined as previously described (8).  A portion of the supernatant was 
used to determine protein concentration by the bicinchoninic acid assay (48) according to 
the manufacturer’s instructions (Pierce Biotechnology catalog no. 23227). The remaining 
supernatant was stored at -80°C until further analyzed.  
Immunoblotting. Aliquots of supernatants from homogenized muscle lysates were 
combined with sodium dodecyl sulfate (SDS) loading buffer and separated by SDS-
PAGE before being electrophoretically transferred to nitrocellulose. Samples were then 
rinsed with Tris-buffered saline plus Tween-20 (TBST) (20mM Tris base, 150mM NaCl, 
pH 7.6, and 0.1% Tween-20), blocked with 5% nonfat dry milk in TBST for 1 hour at 
room temperature, washed 3 x 5 minutes at room temperature, and treated with the 
primary antibody (anti-pAMPK-Thr172 at 1:1,000 in TBST with 5% BSA) overnight at 
4°C. Blots were then washed 3 x 5 minutes with TBST, incubated with the secondary 
antibody, goat anti-rabbit IgG horseradish peroxidase conjugate (1:20,000 in TBST with 
5% milk), for 1 hour at room temperature, washed again 3 x 5 minutes with TBST, and 
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developed with West Dura SuperSignal enhanced chemiluminescence reagent (Thermo 
Fisher Scientific, Waltham, MA). Protein bands were quantified by densitometry (Cell 
Biosciences, Santa Clara, CA). The mean values for sedentary samples without insulin on 
each blot were normalized to equal 1.0, and then all samples on the blot were expressed 
relative to the normalized sedentary without insulin value. 
Muscle glycogen concentration. Muscles used for measurement of glycogen were 
frozen immediately after dissection, weighed, and homogenized in ice-cold 0.3 M 
perchloric acid. An aliquot of the homogenate was stored at -80°C for later determination 
of glycogen concentration by the amyloglucosidase method (40). 
Statistical analyses. Statistical analyses used Sigma Stat version 2.0 (San Rafael, 
CA). Data are expressed as means ± SE. Two-way ANOVA was used to determine 
significant differences between the main effects of exercise and genotype, and a Tukey 
post hoc test was used to identify the source of significant variance.  A P value ≤0.05 was 
considered statistically significant.   
 
RESULTS  
Muscle Glycogen. Epitrochlearis muscle glycogen was reduced in 0hPEX vs. 
0hSED rats, and it was not significantly different for BNK compared to BN rats (Fig. 4.1). 
AMPK Thr172 Phosphorylation. Epitrochlearis AMPK Thr172 phosphorylation was 
increased in 0hPEX vs. 0hSED rats, and it was not significantly different in BNK vs. BN 
rats (Fig. 4.2).   
Muscle Glucose Transport. There was an increase in glucose transport in 0hPEX 
vs. 0hSED in both BN and BNK rats (Fig. 4.3).  There was not a difference between 
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BNK and BN rats for the exercise-induced increase in insulin-independent glucose 
transport.  
Glucose transport without insulin was significantly greater for 3hPEX vs. 3hSED 
rats in (P < 0.05; Fig. 4.4).  There was not a significant effect of genotype (BNK vs. BN) 
on glucose transport without insulin in 3hSED and 3hPEX rats (Fig. 4.4).   
In the insulin-stimulated epitrochlearis, glucose transport was significantly greater 
for 3hPEX vs. 3hSED rats (P < 0.001; Fig. 4.4).  Glucose transport with insulin was not 
different for BNK vs. BN rats in 3hSED and 3hPEX groups.  Paired muscles were used 
for glucose transport measurements, with one muscle from each rat incubated without 
insulin and the contralateral muscle incubated with insulin. We calculated the insulin-
stimulated increase in glucose transport (delta insulin) by subtracting the basal value from 
the insulin-stimulated value for each rat.  Delta insulin was also significantly greater for 
3hPEX vs. 3hSED rats (P < 0.05).  Delta insulin was not different for BNK compared to 
BN rats in the 3hSED and 3hPEX groups. 
There were no significant interactions (exercise x genotype) for any of the 
measurements made. 
 
DISCUSSION  
A single exercise session can cause an increase in both insulin-dependent and 
insulin-independent glucose uptake by skeletal muscle in mice (6, 7, 26), rats (9, 10, 42, 
54), and humans (44, 56).  Several previous studies have demonstrated that the 
Kallikrein-Kininogen System (KKS) can be activated by exercise or muscle contractions 
(33, 49, 52), and it has been suggested that this activation might play a role in elevated 
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glucose uptake by skeletal muscle (19, 21, 50).  The most important new findings of this 
study were that unexercised BN and BNK rats (which are known to be deficient in 
plasma kininogen) did not differ for insulin-stimulated glucose transport, and that the 
effects of exercise on both insulin-independent and insulin-dependent glucose transport 
were undiminished in the BNK rats.  
Results of several published studies suggest that the KKS is linked to insulin-
dependent glucose transport in the absence of exercise, but the results of other published 
studies are not consistent with this idea.   In support, incubation with bradykinin has been 
reported to increase insulin-stimulation of GLUT4 translocation and glucose transport of 
L6 myocytes, 3T3-L1 adipocytes, or isolated dog adipocytes (2, 31, 38).  In addition, 
previous studies found that insulin-stimulated glucose transport was greater in isolated 
epitrochlearis muscles that were dissected from obese Zucker rats that had been injected 
with bradykinin either acutely (2 hours prior to muscle dissection) or chronically (twice 
daily for 14 days) (29, 30).  However, in vivo bradykinin treatment did not enhance 
insulin-stimulated glucose uptake by isolated epitrochlearis muscles from lean Zucker 
rats (29).  Most relevant to the results of the current study, BNK vs. BN rats had a 
significantly reduced glucose disposal rate during a hyperinsulinemic-euglycemic clamp 
(16).  In contrast, the current study did not provide evidence for insulin resistance in the 
isolated epitrochlearis of BNK vs. BN rats.  The results from the in vivo clamp procedure 
would be directly influenced by systemic factors that were absent from the isolated 
muscle preparation, including blood flow, circulating hormones, and neural regulation.  
In addition, glucose disposal in vivo depends on multiple tissues, including the liver, 
adipose tissue, and skeletal muscle. It is also possible that the epitrochlearis is not 
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representative of the glucose uptake by all of the skeletal muscles in the body.  However, 
the fiber type composition of the epitrochlearis (predominantly type IIb) corresponds 
closely to that reported for 32 muscles of the rat hindlimb (1), suggesting it is reasonable 
to use the epitrochlearis as a representative muscle based on fiber type.   It is notable that 
Shimojo et al. (47) also did not find an effect of bradykinin on in vitro, insulin-stimulated 
glucose uptake by the predominantly type I soleus muscle.  The current results clearly 
demonstrate that there is not intrinsic insulin resistance of the isolated epitrochlearis 
(composed of predominantly type II fibers) of BNK rats.     
A number of studies have assessed the possible role of the KKS system in insulin-
independent increase in skeletal muscle glucose transport with exercise or contraction. 
Dietze and Wicklmayr (19) found that most of the isometric exercise-induced increase in 
glucose uptake by the human forearm could be blocked by infusion of aprotinin (a 
kallikrein inhibitor).  They also found that bradykinin infusion could eliminate aprotinin’s 
inhibition of exercise-induced glucose uptake.  Bradykinin can elevate blood flow, so the 
results for forearm glucose uptake during in vivo exercise were likely partly attributable 
to changes in muscle blood flow which was observed to be decreased by aprotinin and 
increased by bradykinin infusion.  Consistent with this interpretation, studying isolated 
rat epitrochlearis muscles, Constable et al. (13) found that a range of bradykinin 
concentrations did not result in increased glucose transport, nor was contraction-
stimulated glucose transport attenuated in the presence of aprotinin.  Insulin-independent 
glucose uptake by L6 myotubes, 3T3-L1 adipocytes, and Chinese hamster ovary cells 
was greater for cells that stably overexpressed both GLUT4 and B2 receptor of 
bradykinin compared to cells that overexpressed only GLUT4 (33).  However, in L6 cells 
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or isolated muscle strips from dogs without overexpression of B2 receptors of bradykinin, 
insulin-independent glucose transport was not elevated by bradykinin (38).  Taguchi et al. 
(50) measured the sarcolemmal GLUT4 content and glucose uptake by sarcolemmal 
vesicles prepared from skeletal muscle that was sampled immediately post-exercise (1 
hour swim by rats).  Exercised rats were studied with or without 5 days of infusion of a 
B2 receptor of bradykinin inhibitor.  The inhibitor caused an ~50% decline in the 
immediate post-exercise increases in membrane GLUT4 and glucose uptake.  It seems 
possible that chronic treatment with a bradykinin B2 receptor inhibitor might induce 
adaptations that altered the effects of exercise on GLUT4 and glucose uptake.  In the 
current study, using isolated epitrochlearis muscles, BNK vs. BN rats were not different 
for insulin-independent glucose transport measured immediately post-exercise.  Although 
the KKS can influence blood flow and thereby indirectly alter in vivo glucose uptake 
during exercise, data from studies that have evaluated glucose transport by isolated 
skeletal muscle (in which blood flow is not a factor) after in vivo exercise or in vitro 
contractions provide no support for the idea that KKS is responsible for increased insulin-
independent glucose transport after exercise or contractions.  
Because exercise can activate the KKS leading to bradykinin production (4, 5, 35, 
50), and because of multiple lines of evidence linking the KKS to enhanced insulin 
sensitivity in intact animals (16, 20, 34, 51) and isolated cells or tissues (2, 17, 30, 31, 38), 
it seemed possible that kininogen-deficient rats might not have a normal post-exercise 
elevation in insulin-stimulated glucose transport.  However, the current results indicated 
that exercise effects on subsequent insulin-stimulated glucose transport are essentially the 
same for BN and BNK rats.  We recently performed a study using the bradykinin B2 
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receptor null mouse as a different model to assess the possible role of the KKS in post-
exercise glucose transport (46).  Isolated skeletal muscles from the mice that were null 
for the B2 receptor of bradykinin and normal control mice did not differ for their post-
exercise increase in insulin-dependent glucose transport after exercise.  The results of 
experiments using two different animal models for important components of the KKS 
provide evidence that a normal KKS is not essential to attain a normal elevation in 
insulin-stimulated glucose transport by isolated skeletal muscles after in vivo exercise. 
Exercise induces AMPK activation and glycogen depletion, and these effects have 
been suggested to be important for both increased insulin-independent and insulin-
dependent glucose transport after exercise (18, 22, 25, 32, 55).  The current results were 
apparently the first to evaluate exercise effects on AMPK phosphorylation or glycogen 
concentration in a KKS model.  Kininogen-deficient rats, compared to normal rats, did 
not have altered glycogen depletion or AMPK activation as indicated by AMPK Thr172 
phosphorylation after exercise.  These observations are consistent with the lack of 
difference seen between the BN and BNK rats for insulin-independent glucose transport 
immediately post-exercise or insulin-dependent glucose transport 3 hours post-exercise.    
Electrical stimulation of isolated skeletal muscle has often been used as model for 
in vivo exercise.  Gao et al. (24) demonstrated that electrically stimulated contraction by 
isolated rat epitrochlearis muscle in the presence of serum, but not in the absence of 
serum, can lead to a subsequent improvement in insulin sensitivity.  They also provided 
convincing evidence that the enhanced insulin-stimulated glucose transport in this model 
requires the presence of a serum protein with molecular mass greater than 10 kDa.  The 
molecular masses of kallikrein and kininogen are greater than 10 kDa, and we (21) 
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previously hypothesized that KKS proteins might be required for the post-contraction 
increase in glucose transport.  In support of this idea, Dumke et al. (21) reported that rat 
epitrochlearis muscles electrically stimulated to contract in kallikrein-deficient plasma 
compared to muscles stimulated to contract in normal plasma had lower insulin-
stimulated glucose transport.  However, in vivo exercise and in vitro contractions in 
serum may not lead to increased insulin-stimulated glucose transport by an identical 
mechanism.  Funai et al. (23) found that when in vivo exercise is followed by rapid 
removal of the epitrochlearis and in vitro contraction of the isolated muscle, the two 
stimuli induced an additive effect on the subsequent increase in insulin-stimulated 
glucose transport.  These results suggested that the increase in insulin-stimulated glucose 
transport induced after in vitro contraction and after in vivo exercise may be caused by 
distinct mechanisms.   The current study focused on the effects of in vivo exercise 
because this intervention is more physiologically relevant than electrical stimulation.  
 In conclusion, insulin-stimulated glucose transport by isolated epitrochlearis 
muscles was similar for sedentary BN and BNK rats.  Rats deficient in plasma kininogen 
compared to normal rats had similar post-exercise increases in both insulin-independent 
and insulin-dependent glucose transport by isolated epitrochlearis muscle.  It is well-
established that exercise has robust effects on insulin-independent and insulin-dependent 
glucose transport that persist in isolated muscles, and the current data indicate that these 
important exercise effects are undiminished in plasma kininogen-deficient rats.   
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Figure 4.1  
Muscle glycogen concentration in isolated epitrochlearis. Muscle glycogen 
concentration in isolated epitrochlearis from BN and BNK rats that were sedentary 
(0hSED) or exercised (0hPEX).  Values are mean ±SE for 7-8 muscles per group. *P < 
0.05 for exercised rats having lesser muscle glycogen than sedentary rats. 
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Figure 4.2 
AMPKThr172 phosphorylation in isolated epitrochlearis. AMPKThr172 phosphorylation 
in isolated epitrochlearis from BN and BNK rats that were sedentary (0hSED) or 
exercised (0hPEX).  Values are mean ±SE for 7-8 muscles per group. *P < 0.05 for 
exercised rats having greater phosphorylation than sedentary rats. 
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Figure 4.3 
Immediate post-exercise glucose transport by isolated epitrochlearis muscle.  
Glucose transport by isolated epitrochlearis muscles without insulin from BN and BNK 
rats that were sedentary (0hSED) or exercised (0hPEX).  Values are mean ± SE for 7-8 
muscles per group. *P < 0.05 for exercised rats having greater glucose transport than 
sedentary rats. 
 
 
 
 
 
 
 
88 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.4 
Three hour post-exercise insulin-stimulated glucose transport by isolated 
epitrochlearis muscle.  Glucose transport by isolated epitrochlearis muscles without or 
with 60μU/mL insulin from BN and BNK rats that had undergone two hours of 
swimming exercise and rested for three hours (3hPEX) or time-matched sedentary 
controls (3hSED).  Delta insulin represents the insulin-stimulated increase above basal in 
glucose transport calculated by subtracting the basal value from the insulin-stimulated 
value of paired muscles. Values are mean ± SE for 15-16 muscles per group. *P < 0.05. 
Exercise, main effect of exercise treatment; Genotype, main effect of genotype; Exercise 
x Genotype, interaction between main effects. 
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CHAPTER V 
 
STUDY 3 
 
Mechanisms for the Prolonged Post-Exercise Increase in AS160 Phosphorylation: 
Roles of Protein Kinases and Phosphatases 
 
ABSTRACT  
A single exercise session can induce a persistent increase in insulin-stimulated glucose 
transport that can last for three or more hours post-exercise.  Sustained AS160 
phosphorylation after exercise has been demonstrated to track with and possibly 
contribute to the persistent post-exercise increase in insulin-stimulated glucose transport 
in a variety of models including rat skeletal muscle.  Two plausible mechanisms that 
potentially lead to sustained AS160 phosphorylation post-exercise are: 1) increased 
activation of kinases that regulate AS160 phosphorylation, and/or 2) decreased activation 
of phosphatases that regulate AS160 dephosphorylation.  Male Wistar rats were randomly 
assigned to exercise (4 x 30 minute swim) or sedentary (3hSED) groups.  Rats were 
anesthetized 3 hours post-exercise (3hPEX), and epitrochlearis muscles were 
isolated. Muscles from 3hPEX versus 3hSED rats had greater AS160Thr642 and 
AS160Ser588 phosphorylation, but none of the known kinases of AS160 (Akt, AMPK, 
RSK, and SGK) had greater phosphorylation in 3hPEX versus 3hSED rats.  As the 
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AS160 phosphatases are unknown, we evaluated the most abundant Ser/Thr phosphatases 
in skeletal muscle (PP1, PP2A, PP2A, and PP2C) for their ability to dephosphorylate 
AS160.  Each of these phosphatases was found to dephosphorylate AS160 on both the 
Thr642 and Ser588 phospho-sites in cell-free conditions.  Furthermore, PP1 and PP2C, 
but not PP2A or PP2B, were found to co-immunoprecipitate with AS160.  Basal or 
insulin-stimulated muscles from 3hPEX versus 3hSED muscles did not differ for the 
amount of PP1, PP2A, PP2B, or PP2C that co-immunoprecipitated with AS160, nor did 
these muscles have altered PP2A Tyr307 phosphorylation or Leu309 methylation.  These 
novel results demonstrated that:  1) the sustained AS160 phosphorylation at three hours 
post-exercise on Thr642 and S588 was not attributable to persistent phosphorylation of 
any of the kinases that are known to phosphorylate AS160; 2) PP1, PP2A, PP2B, and 
PP2C were each able to dephosphorylate the two AS160 phospho-sites that are most 
important for regulating insulin-stimulated glucose transport; 3) Post-translational 
modifications important for PP2A’s activity were not altered by exercise; 4) PP1 and 
PP2C were associated with AS160, while there was no detectable AS160 binding of 
PP2A and PP2B; and 5) the co-immunoprecipitation of each of these phosphatases with 
AS160 was not different in 3hSED versus 3hPEX rat muscles incubated with or without 
insulin.  Our working hypothesis is that the regulation of PP1 and/or PP2C by 
mechanisms other than reduced association with AS160 may contribute to the persistent 
increase in AS160 phosphorylation in muscle after acute exercise.  
 
 
 
95 
 
INTRODUCTION  
A single exercise session can induce a persistent increase in insulin-stimulated 
glucose transport that can last up to 3-48 hours post-exercise (13, 14, 55, 56, 70).  The 
increase in insulin-stimulated glucose transport after acute exercise is attributed to 
increased ability of insulin to recruit GLUT4 to the cell surface after exercise (34) 
without increased total GLUT4 abundance (12).  Many studies have provided evidence 
that greater cell-surface GLUT4 is not attributable to key proximal insulin signaling steps 
including insulin receptor (IR) binding (5-7, 78), IR tyrosine phosphorylation (18, 34, 36, 
67, 74), IR tyrosine kinase activity (66, 67, 72, 74), insulin receptor substrate (IRS) 
tyrosine phosphorylation (34, 36, 73, 74, 76), IRS-associated phosphatidylinositol 3 
kinase (PI3K) activity (22, 27, 66, 73, 74), Akt serine phosphorylation (2, 18, 27, 33, 66, 
72), Akt threonine phosphorylation (31, 33), and Akt activity (31).  
Sano et al. (59) identified an Akt substrate of 160 kDa (also known as AS160 or 
TBC1D4) as a link between insulin’s activation of Akt and the subsequent increase in 
cell-surface GLUT4 in 3T3-L1 adipocytes.  Insulin can also lead to increased AS160 
phosphorylation in skeletal muscle (9), and this increase is important for insulin-
stimulated glucose transport (43).  Additionally, Sano et al. (59) found that Thr642 and 
Ser588 of AS160 are the two primary sites that regulate cell-surface GLUT4 content 
upon insulin stimulation in 3T3-L1 adipocytes.  In rats, the sustained increase in 
phosphorylated AS160 was first recognized using the phospho-Ser/Thr Akt substrate 
(PAS) antibody designed to recognize Akt phosphomotif peptide sequences (41).  The 
PAS antibody was subsequently shown to have differing immunoreactivities for different 
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sites on AS160: highest for Thr642, modest for Ser588, and little to no immunoreactivity 
for Ser318, Ser341, Ser570, and Ser751 (32, 59).   
Our group was the first to report that sustained AS160 phosphorylation (using the 
PAS antibody and an antibody against the Thr642 site) closely tracked with the post-
exercise increase in insulin-stimulated glucose transport in rat skeletal muscle (2, 30, 31).  
Our working hypothesis is that the persistent AS160 phosphorylation post-exercise may 
be important for the increase in insulin-stimulated glucose transport after acute exercise.  
Sustained AS160 phosphorylation after exercise was later found in humans.  In human 
skeletal muscle samples collected during a hyperinsulinemic-euglycemic clamp four 
hours after one-legged treadmill exercise versus non-exercised muscle, AS160 
phosphorylation has been shown to be elevated on several sites including Ser318, Ser341, 
Ser751, and a strong trend for elevation at Ser588, but no elevation for Thr642 (68).  As 
phosphorylation of the Ser588 site of AS160 had not yet been demonstrated in rat skeletal 
muscle, the first aim of this study was to determine if AS160 Ser588 phosphorylation is 
enhanced post-exercise in rat skeletal muscle as was previously shown on AS160 Thr642 
(31).   
The mechanism for the persistent elevation in AS160 phosphorylation after acute 
exercise is unknown, but two plausible mechanisms that might lead to sustained 
phosphorylation of a protein are: 1) increased kinase activity on the substrate and/or 2) 
decreased phosphatase activity on the substrate.  Geraghty et al. (32), using a cell-free 
assay, identified several kinases that are capable of phosphorylating AS160: AMPK and 
several AGC (named after protein kinase A, protein kinase G, and protein kinase C, the 
original members of this class) protein kinase family members (Akt, SGK, RSK).  
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However, Akt and AMPK have been shown to not be phosphorylated on sites that are 
required for greater enzyme activity in epitrochlearis muscles with increased AS160 
phosphorylation three to four hours after exercise (2, 31).  Another AGC protein kinase 
that has been reported to be activated by some exercise protocols, p70S6K, has not been 
previously evaluated for its ability to phosphorylate AS160 (3, 15, 20, 28) in spite of its 
consensus motif implicating AS160 as a possible target (25, 53).  Therefore, a second aim 
was to determine if SGK, RSK, and/or p70S6K are phosphorylated three hours post-
exercise in skeletal muscles with elevated AS160 phosphorylation.   
The protein phosphatases that are able to dephosphorylate AS160 have not been 
identified.  Serine/threonine protein phosphatase 1 (PP1), 2A (PP2A), 2B (PP2B), and 2C 
(PP2C) are the most highly expressed serine/threonine protein phosphatases by skeletal 
muscle (21, 35, 38, 61, 71).  Therefore, the third aim was to determine if PP1, PP2A, 
PP2B, and/or PP2C, using cell-free assays, are able to dephosphorylate AS160 from rat 
skeletal muscle that had been phosphorylated via prior insulin stimulation.   
It would be valuable to elucidate the mechanisms at which PP1, PP2A, PP2B, 
and/or PP2C are regulated in skeletal muscle.  A potential mechanism for regulating 
dephosphorylation of AS160 would be to alter the amount of phosphatase(s) associated 
with AS160.  Therefore, the fourth aim was to determine if AS160 co-
immunoprecipitates with PP1, PP2A, PP2B, and/or PP2C in rat skeletal muscle from 
sedentary rats.  Furthermore, the fifth aim was to determine if prior exercise or insulin 
treatment alters AS160 association with any of these protein phosphatases.   
Finally, PP2A has been shown to be regulated via post-translational modifications 
on its catalytic subunit.  The activity of the catalytic subunit of PP2A can be altered with 
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PP2A tyrosine phosphorylation at the 307 site, so a change in phosphorylation on the 
Tyr307 site is a possible mechanism for reducing PP2A effects on substrates (40, 46, 65).  
Additionally, methylation on the Leu309 site of the catalytic subunit of PP2A has been 
reported to play a role in the assembly of the heterotrimeric enzyme, specifically by 
influencing which regulatory subunit is associated with the PP2A complex (10, 24, 48, 
77). There is also some evidence that methylation of this site may regulate PP2A activity 
(24, 26, 49, 77).  Neither of these sites have been evaluated in skeletal muscle and the 
final aim was to determine if tyrosine phosphorylation or leucine methylation on PP2A’s 
catalytic site were altered immediately or 3h post-exercise, concomitant with sustained 
AS160 phosphorylation.   
 
METHODS  
Materials. Human recombinant insulin was obtained from Eli Lilly (Indianapolis, 
IN). Reagents and apparatus for SDS-PAGE and immunoblotting were purchased from 
Bio-Rad (Hercules, CA). Bicinchoninic acid protein assay reagent (no. 23227), T-PER 
tissue protein extraction reagent (no. 78510), and West Dura Extended Duration 
Substrate (no. 34075) were purchased from Pierce Biotechnology (Rockford, IL). Goat 
anti-rabbit IgG horseradish peroxidase conjugate (no. 7074), anti-phospho-Thr308 Akt 
(no. 9275), anti-p70 ribosomal S6 Kinase (p70S6K; no. 9202), anti-phospho-Thr389 
p70S6K (no. 9205), anti-ribosomal S6 kinase 1 antibody (RSK1; no.9333), anti-phospho-
Ser380 RSK1 (no. 9341), anti-AMPKα (no. 2532), anti-phospho-Thr172 AMPKα (no. 
2531) were purchased from Cell Signaling Technology (Danvers, MA). Anti-phospho-
Thr642 AS160 (no.07-802), anti-serum- and glucocorticoid-induced protein kinase 1 
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(SGK1; no. 07-315), anti-phospho-Thr256 SGK1 (no.36-002), anti-PP1α (no. 07-273), 
anti-calcineurin pan A [anti-PP2B pan A] (no. 07-1491), anti-AS160-serum (no. 07-741), 
anti-AS160-purified (no. ABS54), and protein G agarose beads (no. 16-266) were 
purchased from Millipore (Billerica, MA).  Protein A Sepharose Beads 6MB (17-0469-
01) were purchased from GE Healthcare (Piscataway, NJ).  Anti-PP2A catalytic α (no. 
610555) was purchased from BD Biosciences (San Jose, CA).  Recombinant PP2A (no. 
V6311) was purchased from Promega (Madison, WI).  Recombinant PP1 (no. P0754) 
was purchased from New England Biolabs (Ipswich, MA).  Recombinant 
PP2B/calcineurin and calmodulin was included in the Calcineurin Activity Kit (no. BML-
AK816-0001) and was purchased from Enzo Life Sciences (Farmingdale, NY). 
Recombinant PP2Cα isoform (no. 539569) was purchased from EMD Chemical 
(Gibbstown, NJ). Anti-PP2Cα/β (no. ab27267) and anti-phospho-Thr642 AS160 (no. 
ab65753) used in cell-free assay experiments was purchased from Abcam (Cambridge, 
MA).  Anti-phospho-Tyr307 PP2A-Cα/β (no. sc-12615), Anti-methyl-PP2A-Cα/β (no.sc-
81603), Anti-PP2Cα (no. sc-32402), and donkey anti-goat IgG-HRP (no. sc-2020) was 
purchased from Santa Cruz Biotechnology (Santa Cruz, CA). Anti-phospho-Ser588 
AS160 (no. 3028-P2) was purchased from B-Bridge International (Mountain View, CA). 
3-O-methyl-[ 3H]glucose ([3H]3-MG) was purchased from Sigma-Aldrich (St. Louis, 
MO).  [14C]Mannitol was purchased from PerkinElmer (Waltham, MA). Other reagents 
were purchased from Sigma-Aldrich or Fisher Scientific (Pittsburgh, PA).   
Animal treatment. Procedures for animal care were approved by the University of 
Michigan Committee on Use and Care of Animals. Male Wistar rats (~135–200 g; Harlan, 
Indianapolis, IN) were provided with rodent chow (Lab Diet; PMI Nutritional 
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International, Brentwood, MO) and water ad libitum. Starting at 1700 on the night before 
the experiments, rats were fasted. On the following day, rats were randomly assigned to a 
post-exercise (PEX) or sedentary (SED) treatment. Beginning at ~0900, PEX rats swam 
in a barrel filled with water (35°C) to a depth of ~60 cm (7 or 8 rats/barrel) for 4 x 30 min 
bouts, with a 5-min rest period between each bout.  Rats were anesthetized with an 
intraperitoneal injection of pentobarbital sodium (5mg/100 g body wt) either immediately 
post-exercise (0h PEX) or 3-4h post-exercise (3h PEX) along with time-matched 
sedentary rats.  While the rats were under deep anesthesia, both epitrochlearis muscles 
were rapidly dissected out and either freeze-clamped immediately or transferred to vials 
for subsequent incubation. 
Muscle incubations. For the 0hPEX experiment, following anesthetization, one 
epitrochlearis muscle from each rat was rapidly dissected out, trimmed, freeze-clamped 
using aluminum clamps cooled to the temperature of liquid N2, and stored at -80°C until 
analyzed. After dissection, the contralateral muscle from the 0hPEX group and the time-
matched SED group were incubated for 10 min at 30°C in flasks containing in KHB + 
BSA + 2 mM pyruvate + 6mM mannitol (solution 2) at 30°C for 10 min and then 
transferred to flasks containing KHB, 0.1% BSA with 8 mM 3-MG (including 0.25 
mCi/mmol [3H]3-MG), and 2 mM mannitol (including 0.1 mCi/mmol [14C]mannitol) 
(solution 3). For all incubation steps, flasks were continuously gassed from above with 
95% O2-5% CO2 and shaken in a heated water bath.  
For the 3hPEX experiment, rats were dried following the final exercise bout and 
returned to their cage for 3h before being anesthetized.  Time-matched SED rats were 
also anesthetized and then epitrochlearis muscles were dissected out.  Both epitrochlearis 
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muscles from each animal was incubated in Krebs-Henseleit buffer (KHB) + 0.1% 
bovine serum albumin (BSA) + 8 mM glucose + 2 mM mannitol (solution 1) for 30 min 
in a water bath at 35°C. During this step, one muscle from each rat was incubated in 
solution 1 supplemented with 50 µU/ml of insulin, and the contralateral muscle was 
incubated in solution 1 without insulin. The same insulin concentration was used for each 
muscle during all subsequent incubations. After the initial incubation, muscles were 
transferred to vials containing solution 2 with or without 50 µU/ml insulin at 30°C for 10 
min. Finally, muscles were transferred to flasks containing solution 3 with or without 50 
µU/ml insulin for determination of glucose transport rate. After incubation with 3-MG for 
15 min, the muscles were rapidly blotted on filter paper dampened with incubation 
medium, trimmed, freeze-clamped, and stored at -80°C until being processed as described 
below.  
Homogenization and glucose transport measurement. Frozen muscles were 
homogenized in 1 ml ice-cold homogenization buffer (1% Triton X-100, 1 mM activated 
Na3VO4, 20mM Tris-HCl pH 7.4, 150 mM NaCl, 1 mM EDTA, 1 mM EGTA, 2.5 mM 
sodium pyrophosphate, 1 mM β-glycerophosphate, 1 mM phenylmethanesulfonyl 
fluoride, and 1 µg/ml leupeptin in water) using glass-on-glass tubes (Kontes, Vineland, 
NJ) or high-speed tissue disruption with the TissueLyser II (Qiagen, Valencia, CA). 
Homogenates were subsequently solubilized by rotating at 4°C at 50 rpm for 1 h before 
being centrifuged (15,000 g for 15 min at 4°C). Aliquots of the supernatant from muscles 
used for the 3-MG transport measurement were pipetted into vials with scintillation 
cocktail for scintillation counting, and 3-MG transport were determined as previously 
described (11). A portion of the supernatant were used to determine protein concentration 
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by the bicinchoninic acid assay (63) according to the manufacturer’s instructions (Pierce 
Biotechnology; no. 23227). The remaining supernatant was stored at -80°C until further 
analyzed.  
Immunoprecipitation. Aliquots of the homogenates prepared as described above 
(300 µg protein) were brought to the same volume to equalize the concentration of 
muscle lysates and were precleared with 100 µL of protein G agarose beads or protein A 
sepharose beads for 1 h. When using protein G agarose beads for the 
immunoprecipitation of SGK, the muscle lysates were mixed with an immuno-matrix of 
100 µL of protein G agarose beads that had been gently rotated with 3 µg/µL of anti-
AS160 for 1 h.  The lysate-antibody-protein G mixture was gently rotated overnight at 
4°C at 5 rpm.  When using protein A sepharose beads were used for immunoprecipitation 
of AS160, the supernatant from the muscle lysates were gently rotated with 2 µg for 3 
hours and then 25 µL of a 50/50 slurry of protein A sepharose beads were added.  The 
lysate-antibody-protein A mixture was gently rotated overnight.  Following overnight 
rotation in both protein G agarose and protein A sepharose immunoprecipiation assays, 
the immunoprecipitation mix was centrifuged (4000g) and supernatant were aspirated.  
An aliquot of the aspirated supernatant was used to assess immunoprecipitation 
efficiency by comparing against immunoprecipated samples bound to the beads via 
densitometry analysis.  After washing (4 times with 500 µL PBS), immunoprecipitated 
proteins were eluted with 2X Laemmli sample buffer, boiled, and subjected to SDS-
polyacrylamide gel electrophoresis (PAGE). For the cell-free assays, after washing (3 
times with 500 µL PBS and 2 times with the appropriate phosphatases buffer [described 
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below]), immunoprecipitated AS160 was eluted with 2X Laemmli sample buffer (1:1 
volume), boiled, and subjected to SDS-PAGE. 
Immunoblotting and protein phosphorylation. Homogenized muscle lysates were 
subjected to SDS-PAGE and immunoblotted to nitrocellulose membranes. Blots were 
then rinsed with Tris-buffered saline plus Tween (TBST) (0.14 mol/l NaCl, 0.02 mol/l 
Tris base, pH 7.6, and 0.1% Tween), blocked with 5% BSA in TBST for 1 h at room 
temperature, washed 3 x 5 min at room temperature, and incubated with the relevant 
primary antibody (1:1,000 in TBST + 5% BSA) overnight at 4°C. Blots were then 
washed 3 x 5 min with TBST, incubated with the relevant secondary antibody (goat anti-
rabbit, goat anti-mouse, goat-anti-sheep) IgG horseradish peroxidase conjugate (1:20,000 
in TBST + 5% BSA), for 1 h at room temperature, washed again 3 x 5 min with TBST, 
and developed with SuperSignal reagent. Protein bands were quantified by digital 
densitometry (ProteinSimple, Santa Clara, CA). The mean values for sedentary samples 
without insulin on each blot were normalized to equal 1.0, and then all samples on the 
blot were expressed relative to the normalized sedentary without insulin value. 
Cell-free dephosphorylation assay using recombinant PP1, PP2A, PP2B, or 
PP2C. AS160 that had been immunoprecipitated from lysates prepared from 
epitrochlearis muscles that had been incubated with insulin (2000 μU/ml for 30min to 
induce high levels of AS160 phosphorylation) were used to assess the ability of 
recombinant PP1, PP2A, PP2B, and PP2C to dephosphorylate AS160Thr642 and 
AS160Ser588.  The immunoprecipitated AS160 (as described above) was incubated for 2 hr 
at 30°C with gentle shaking in the appropriate buffer for each phosphatase. PP1 buffer 
was 50mM HEPES, 100nM NaCl, 2mM DTT, 1mM MnCl2 in 0.01% Brij35 (pH 7.5). 
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PP2A buffer was 50mM Tris-HCl (pH 8.5), 20mM MgCl2, and 1mM DTT. PP2B buffer 
was 50mM Tris (ph7.5), 100mM NaCl, 6mM MgCl2, and 0.5mM DTT, 1mM CaCl2, 
0.05% NP-40, and 0.5μM calmodulin. PP2C buffer was 20mM Tris-HCL (pH 7.4), 
10mM MnCl2, 0.5mM EGTA (pH 8.0), 3mM 2-mercaptoethanol in 0.2 mg/ml BSA.  The 
reactions were terminated by adding SDS loading buffer (2X) to the reaction and boiling 
the sample for 5 min.  Samples were subsequently subjected to SDS-PAGE, imunoblotted 
to nitrocellulose membranes, and blots were probed with anti-phospho-Thr642 AS160 
and anti-phospho-Ser588 AS160 (17).  Following AS160Thr642 and AS160Ser588 
phosphorylation detection, blots were stripped (20 min of shaking in 0.2M glycine in 
0.05% Tween 20 at 70°C) and reprobed with an antibody against total AS160 to verify 
equal loading. 
Statistical analyses. Statistical analyses were done using Sigma Stat version 2.0 
(San Rafael, CA). Data were expressed as means ± SE. When an analysis comparing four 
groups was required, a two-way ANOVA was used to determine significant differences, 
and a Tukey post hoc test was used to identify the source of significant variance.  When 
an analysis comparing 2 groups was required, a t-test was used to determine significant 
differences.  A P value ≤0.05 was considered statistically significant. 
 
RESULTS 
 3-MG transport. Insulin-independent glucose transport measured immediately 
post-exercise was 3-4 fold greater than time-matched sedentary controls (P < 0.05; Fig. 
5.1A).  This effect was reversed in muscles dissected from rats that were returned to their 
cage following exercise without access to food for 3 hours (3hPEX).  Muscles stimulated 
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with a submaximally effective insulin dose (50µU/ml) had greater glucose transport than 
paired muscles incubated without insulin for both 3hSED (~2 fold greater; P < 0.05) and 
3hPEX (3-4 fold greater; P < 0.05; Fig. 5.1B) rats.  3hPEX rats versus 3hSED rats had 
significantly greater glucose transport for insulin-stimulated muscle (P < 0.05; Fig. 5.1B). 
AS160 phosphorylation. AS160Thr642 and AS160Ser588 phosphorylation were 
increased in 0hPEX versus 0hSed rats (P < 0.05; Fig. 5.2A-B).  AS160Thr642 and 
AS160Ser588 were increased with insulin in both 3hSED and 3hPEX rats (P < 0.05; Fig. 
5.2C-D).  Additionally, for 3hPEX rats versus 3hSED rats in the absence of insulin, there 
were residual and significant increases in AS160Thr642 and AS160Ser588 phosphorylation 
(P < 0.05; Fig. 5.2C-D).   
Kinases.  Among all of the kinases that were assessed for phosphorylation in the 
absence of insulin, there was only a significant increase in AMPKThr172 at 0hPEX versus 
0hSED (P < 0.05; Fig. 3A), and there were no exercise-related differences in AktThr308, 
RSKSer380, SGKThr256, and p70S6KThr389 at 0hPEX (Fig. 5.3B-E).   
AktThr308 phosphorylation was increased with insulin in both 3hSED and 3hPEX 
rats (P < 0.05), and AktThr308 phosphorylation in muscles incubated with insulin was 
greater for 3hPEX versus 3hSED (P < 0.05; Fig. 5.4B), consistent with our previous 
results (2, 31). However, there was no residual increase in AktThr308 phosphorylation in 
3hPEX versus 3hSED rats in muscles incubated without insulin (Fig. 5.4B).  AktSer473 
phosphorylation was increased with insulin in both 3hSED and 3hPEX rats (P < 0.05), 
but there was no difference in insulin-stimulated AktSer473 phosphorylation in 3hPEX rats 
versus 3hSED rats (Fig. 5.4C).   
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RSKSer380 phosphorylation was not significantly altered with insulin in either 
3hSED or 3hPEX rats, and there was a trend for a decrease in RSKSer380 phosphorylation 
in 3hPEX versus 3hSED rats (P = 0.15; Fig. 5.4D).  AMPKThr172, SGKThr256, and 
p70S6KThr389 phosphorylation were not significantly different with or without insulin in 
either 3hSED or 3hPEX rats, and there was no significant difference for each of these 
kinases at 3hPEX versus 3hSED (Fig 5.4A, 5.4E, and 5.4F, respectively).   
Cell-free phosphatase assays with AS160. PP1, PP2A, PP2B, PP2C are expressed 
in skeletal muscle (21, 35, 61, 71).  Recombinant PP1, PP2A, PP2B, and PP2C were each 
able to dephosphorylate insulin-stimulated AS160Thr642 and AS160Ser588 phosphorylation 
in rat epitrochleraris muscle under cell-free conditions (Table 5.1 and Fig. 5.5A-D). 
Co-immunoprecipitation of AS160 and phosphatases catalytic subunits.  
Duplicate aliquots for each sample were loaded in lanes 1 and 2 and had been treated 
identically except that an antibody against total AS160 was present for the sample loaded 
in lane 1 and absent for the sample loaded in lane 2 (Fig. 5.6A).  As seen in lane 1 of the 
immunoprecipitation (IP) blot, the AS160 antibody was highly efficient for precipitating 
AS160 as there is little to no detectable AS160 in the post-immunoprecipitation 
supernatant (PIPS).  As seen in lane 2, the lack of an antibody against total AS160 
resulted in no detectable AS160 in the immunoprecipitation, but rather AS160 was 
detected in the PIPS.   
Immunoblotting for PP1 revealed detectable AS160-PP1 association on the IP 
blot and non-AS160-bound PP1 in the PIPS blot (Lane 1, Fig. 5.6B).  PP1 was not 
detected in the IP blot when the total AS160 antibody was not included, but PP1 was 
found in the PIPS (Lane 2, Fig. 5.6B).   
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Immunoblotting for PP2A revealed detectable AS160-PP2A association on the IP 
blot and non-AS160-bound PP2A in the PIPS blot (Lane 1, Fig. 5.6C).  However, PP2A 
was also detected when the total AS160 antibody was not included, and the amount of 
PP2A was not significantly different when the results were compared with anti-AS160 
included (Lane 1, Fig. 5.6C) versus without the AS160 antibody included (Lane 2, Fig. 
5.6C) indicating that the AS160 antibody was not specifically pulling down AS160-
bound-PP2A.  Additionally, PP2A was also found in the PIPS when the AS160 antibody 
was not included (Lane 2, Fig. 5.6C). 
Immunoblotting for PP2B revealed no detectable AS160-PP2B association on the 
IP blot, and non-AS160-bound PP2B in the PIPS blot (Lane 1, Fig. 5.6D).   
Immunoblotting for PP2C revealed detectable AS160-PP2C association on the IP 
blot and non-AS160-bound PP2C in the PIPS blot (Lane 1, Fig. 5.6E).  PP2C was not 
detected when the total AS160 antibody was not included, but was found in the PIPS 
(Lane 2, Fig. 5.6E).   
Exercise effects on co-immunoprecipitation of AS160 and phosphatase catalytic 
subunits. The amount of PP1alpha catalytic subunit-AS160 association was not altered 
with or without insulin in 3hSED and 3hPEX rats (Fig. 5.6B).  The absence of any 
detectable PP2Aalpha catalytic subunit-AS160 association above the non-specific 
association of PP2A with protein A sepharose beads in the absence of anti-AS160 was 
found with or without insulin in 3hSED and 3hPEX rats (Fig. 5.6C).  PP2B catalytic 
subunit using a pan-PP2B-isoform antibody was not found to be associated with AS160 
regardless of prior exercise of incubation of muscles with insulin (Fig. 5.6D).  
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PP2Calpha/beta-AS160 association was not altered with or without insulin in 3hSED and 
3hPEX rats (Fig. 5.6E).  
Post-translational modifications of PP2A. There was no difference in PP2ATyr307 
phosphorylation or PP2ALeu309 methylation in 0hSED versus 0hPEX rats (Fig.. 5.7A-B).  
PP2ATyr307 phosphorylation was not altered by incubation with insulin or by prior 
exercise (Fig. 5.7C).  PP2ALeu309 methylation was also not altered by incubation with 
insulin or by prior exercise (Fig. 5.7D). 
 
DISCUSSION 
 An acute bout of exercise has long been known to enhance insulin’s ability to 
increase glucose transport in skeletal muscle after the initial insulin-independent glucose 
transport effects of exercise have worn off.  This has been attributed, not to an increase in 
GLUT4 abundance, but rather to the amount of GLUT4 translocating to the cell 
membranes.  However, the mechanism for this increase in GLUT4 translocation is 
unknown.  This effect does not appear to be due to increased activation of proximal steps 
in the insulin signaling pathway, but AS160, a distal signaling step, has been reported to 
have a sustained increase in phosphorylation for hours after acute exercise (2, 30, 31).   
Lienhard’s group investigated the contribution of specific AS160 phospho-sites to 
insulin-stimulated GLUT4 translocation in adipocytes.  Mutation of the Thr642 (to 
Ala642) site and Ser588 (to Ala588) resulted in a ~50% decrease and a ~25% decrease, 
respectively, in insulin-stimulated GLUT4 translocation compared to normal vector 
controls.  Mutating both sites simultaneously resulted in an even greater (~75%) decrease 
in insulin-stimulated GLUT4 translocation compared to normal vector controls, but 
109 
 
mutating additional phospho-sites did not result in a further decrease in insulin-stimulated 
GLUT4 translocation suggesting that Thr642 and Ser588 sites account for most of 
AS160’s effects on insulin-stimulated GLUT4 translocation (59).  We confirmed earlier 
results (31) showing that AS160Thr642 phosphorylation is sustained three hours post-
exercise (Fig. 5.2A), and demonstrated for the first time that AS160Ser588 phosphorylation 
is also sustained three hours post-exercise in rat skeletal muscle (Fig. 5.2B). Therefore, it 
is notable that the two phospho-sites of AS160 that are known to be important for insulin-
stimulated GLUT4 translocation (Thr642 and Ser588) have sustained phosphorylation in 
rat skeletal muscle long after acute exercise.  
Increased activation of kinases that regulate AS160 phosphorylation is one 
plausible mechanism to explain sustained AS160 phosphorylation after exercise.  
Therefore, all the known AS160 kinases were investigated.  Four kinases (Akt, AMPK, 
RSK, and SGK) have been shown to phosphorylate AS160 in cell free assays (32).  
AMPK phosphorylation on the site essential for its kinase activity (64) was increased 
immediately post-exercise.  Because there was no immediate post-exercise increase in the 
phosphorylation of other known AS160 kinases, these results implicate AMPK as the 
leading candidate to account for the exercise-induced increase in AS160 phosphorylation.  
Supporting the idea that AMPK is important for exercise effects on AS160 
phosphorylation, prior studies reported that incubation of isolated skeletal muscle with an 
AMPK inhibitor resulted in decreased contraction-stimulated AS160 phosphorylation 
(29), and AMPK kinase dead-mice had decreased contraction-stimulated AS160 
phosphorylation in skeletal muscle (42).   
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The exercise effect on AMPK phosphorylation observed immediately after 
exercise had reversed at three hours post-exercise indicating that sustained AMPK 
phosphorylation does not explain sustained AS160 phosphorylation.  However, one 
scenario could be that while AMPK phosphorylation was reversed at three hours post-
exercise, it may not yet be completely reversed at ~1-2 hours post-exercise.   Two lines of 
evidence are not consistent with the idea that incompletely reversed AMPK activation at 
1-2 hours after completion of the exercise is a likely mechanism for the sustained AS160 
thereafter.  The first line of evidence is that, immediately post-exercise, the 
phosphorylation of each of the 3 AMPK substrates  that were evaluated (AS160, ACC 
and TBC1D1) is increased, but there is sustained phosphorylation  at 3-4 hours post-
exercise only for AS160 (i.e., not for ACC and TBC1D1) (2, 31).   The second line of 
evidence is that elevated AS160 phosphorylation in the epitrochlearis muscles persists for 
at least 27 hours post-exercise versus sedentary controls (31).  The simplest interpretation 
of the available evidence is that the sustained phosphorylation of AS160 is not 
attributable to persistent activation of AMPK.     
In addition, we found no evidence that phosphorylation of Akt, RSK, and SGK on 
sites known to be required for increased kinase activity (1, 23, 44, 51) was increased 
either immediately or three hours after exercise.  Additionally, we evaluated p70S6K as a 
possible AS160 kinase because its consensus motif for AS160 phospho-sites is similar to 
that of SGK and RSK (25, 53).  However, we found no changes in phosphorylation of 
p70S6K on sites known to be required for its increased kinase activity (54) either 
immediately or three hours post-exercise when compared to sedentary controls.   
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While phosphorylation of the 5 kinases on the phospho-sites that were studied is 
essential for increased kinase activity of these enzymes, it remains possible that one or 
more of these kinases can influence AS160 phosphorylation by other mechanisms [e.g., 
by altered subcellular localization of the kinase(s)].  However, it is notable that although 
the same exercise protocol used in the current study caused increased phosphorylation of 
TBC1D1 [a paralog protein of AS160, and substrate of both AMPK and Akt (16)] 
immediately post-exercise (31), there is not a sustained increase in TBC1D1 
phosphorylation in rat epitrochlearis muscle 3-4 h post-exercise, arguing against 
sustained activation of these kinases.  Nonetheless, it remains possible that other 
unknown kinases are also able to phosphorylate AS160, and these unidentified kinases 
may have a sustained increase in activity after exercise.   
In the absence of any evidence supporting increased phosphorylation of AS160 by 
any of the known AS160 kinases, it was logical to consider that decreased phosphatase 
activity may contribute to the sustained AS160 phosphorylation after acute exercise.  As 
there are no known AS160 phosphatases and a number of phosphatase candidates to 
consider, we began investigating the phosphatases that account for over 99% of the 
serine/threonine phosphatase activity in skeletal muscle (PP1, PP2A, PP2B, and PP2C) to 
see if they have the ability to dephosphorylate AS160 (21, 35, 38, 61, 71).  Under cell-
free conditions, each of the four phosphatases was found to dephosphorylate insulin-
stimulated AS160 at both the Thr642 and Ser588 phospho-sites.  These results provide 
the first information about the specific phosphatases that are able to dephosphorylate 
AS160. 
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Because the cell-free conditions do not represent normal physiology in the 
skeletal muscle, it was important to find endogenous physiological evidence supporting 
regulation of AS160 phosphorylation by phosphatases.  Multiple studies have shown that 
protein phosphatases can associate with target substrates as assessed by co-
immunoprecipitation. PP2A is the most well-studied in this regard as it known to 
associate with AGC protein kinases, such as Akt (8, 39, 47, 75), p70S6K (19), and 
protein kinase C (45).  Additionally, PP1, PP2B, and PP2C have been reported to 
associate with substrates, and PP1 and PP2A both have been shown to associate with the 
same target substrates indicating multiple phosphatases can associate with the same 
protein (4, 58, 60).  Accordingly, we investigated each of the phosphatases to find out if 
AS160 from rat epitrochlearis muscle was associated with these highly expressed 
serine/threonine phosphatases.  Furthermore, we tested if this association is reduced in 
epitrochlearis muscles from rats that had undergone prior exercise and/or incubation with 
insulin.  With the exception of PP2C, the phosphatases investigated are proteins 
consisting of multiple subunits.  There is great diversity in the number of scaffolding (for 
PP2A) and regulatory subunits (for PP1, PP2A, and PP2B).  The catalytic subunit for 
each phosphatase was investigated because this subunit is essential for dephosphorylating 
proteins. 
PP1 specifically co-immunoprecipitated with AS160 in rat epitrochlearis muscle 
providing evidence that PP1 is associated with AS160.  This association was not altered 
in samples from 3hPEX versus 3hSED rats, with or without insulin incubation.  These 
results suggest that reduced PP1-AS160 association does not account for sustained 
increase in AS160Thr642 and AS160Ser588 phosphorylation after exercise. 
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PP2A did not specifically co-immunoprecipitate with AS160 in rat epitrochlearis 
muscle as the detection of PP2A without total AS160 antibody indicates that PP2A in the 
lysate is binding to the beads.  There was no detectable evidence for specific PP2A-
AS160 association above the large amount of non-specific PP2A-bead binding in the 
absence of the AS160 antibody.  Furthermore, we were unable to detect any evidence for 
specific PP2A-AS160 association in samples from exercised rats, with or without insulin 
incubation. 
The activity of PP2A can be regulated by post-translational modifications on the 
catalytic subunit.  Multiple lines of evidence have shown that PP2ATyr307 phosphorylation 
results in decreased activity of the catalytic subunit (40, 46, 65).  Additionally, 
PP2ALeu309 methylation has been reported to result in decreased (49, 77), increased (26), 
or no changes (24) in PP2A activity.  PP2ATyr307 phosphorylation and PP2ALeu309 
methylation were not altered in epitrochlearis muscles dissected immediately after 
exercise versus sedentary controls, or in muscles incubated with or without insulin after 
being dissected from rats dissected three hours after exercise or from sedentary controls. 
These results suggest that these post-translational modifications of PP2A’s catalytic 
subunit do not explain sustained AS160 phosphorylation under these conditions. 
PP2B, also known as calcineurin, was not found to co-immunoprecipitate with 
AS160 in rat epitrochlearis muscle.  We also were unable to detect evidence for PP2B-
AS160 association in samples from exercised rats, with or without insulin incubation, in 
spite of detecting PP2B present in the skeletal muscle lysate.   
PP2C specifically co-immunoprecipitated with AS160 in rat epitrochlearis muscle 
providing evidence that PP2C is associated with AS160.  However, this association was 
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not altered in samples from 3hPEX versus 3hSED rats, with or without insulin incubation.  
These results suggest that reduced PP2C-AS160 association does not account for the 
sustained increase in AS160Thr642 and AS160Ser588 phosphorylation after exercise. 
Considering all of the phosphatase data together, PP1 and/or PP2C appear to be 
the most promising candidate phosphatases of AS160 as each can dephosphorylate 
AS160 on both phospho-sites important for insulin-stimulated GLUT4 translocation and 
each can associate with AS160 based on co-immunoprecipitation.  However, it is 
important to note that these results do not eliminate the possibility of PP2A or PP2B 
having a role in the regulation of AS160 as both were also capable of dephosphorylating 
AS160, and their regulation of sustained AS160 phosphorylation may be independent of 
co-immunoprecipitation with AS160.  For example, AS160 association with these 
phosphatases may be a transient process, and the analysis therefore missed the time in 
which to detect the association.  Alternatively, the treatments used in the co-
immunoprecipitation procedure may have caused disassociation of AS160 from these 
particular phosphatases.   
Given that the amount of PP1 and PP2C associated with AS160 is unaltered after 
exercise, what are possible mechanisms whereby these serine/threonine phosphatases 
might contribute to sustained AS160 phosphorylation after exercise?  One possibility is 
that the activity of PP1 and/or PP2C is attenuated by protein-protein interaction with a 
regulatory protein.   Consistent with this idea, PP1 activity has been shown to be 
regulated by proteins that target the catalytic subunit, altering phosphatase activity (37, 
50, 57), and PP1 catalytic activity has been reported to be altered by proteins targeting 
the regulatory subunit  (52, 62, 69).  A second possibility is that AS160 itself is somehow 
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modified, e.g., by a post-translational modification, allosteric processes, and/or binding to 
a regulatory protein.   In this second speculative model, the putative modification of 
AS160 might induce a conformational change that makes its phospho-sites less 
susceptible to dephosphorylation by the PP1 and/or PP2C that is bound to AS160. 
The main findings in rat epitrochlearis muscles indicate that: 1) both phospho-
sites of AS160 that are important for insulin-stimulated GLUT4 translocation (Thr642 
and Ser588) have increased phosphorylation both immediately and three hours post-
exercise; 2) of the known AS160 kinases, only AMPK phosphorylation was increased 
immediately post-exercise implicating that AMPK in the exercise-induced increase in 
AS160 phosphorylation at this time; 3) sustained phosphorylation of the known kinases 
of AS160 does not appear to explain greater AS160 phosphorylation at three hours post-
exercise; 4) all four of the Ser/Thr phosphatases that were studied have the ability to 
dephosphorylate AS160 on both the Thr642 and Ser588 phospho-sites; 5) PP1 and PP2C, 
but not PP2A or PP2B, are specifically associated with AS160 based on co-
immunoprecipitation; 6) prior exercise or incubation with insulin did not alter post-
translational modifications of PP2A; and 7) prior exercise or incubation with insulin did 
not alter the association of AS160 with the phosphatases.    
Protein phosphorylation status represents the balance between the actions of 
kinases and phosphatases.  Although the prevailing view in signaling research has 
focused more heavily on kinases than on phosphatases, neither the current study nor 
earlier research provides evidence for sustained post-exercise activation of any of the 
known AS160 kinases.  Furthermore, the sustained phosphorylation of AS160 is not 
typical, i.e., there is no evidence that prior exercise leads to a global increase in the 
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phosphorylation of other substrates of these kinases.  These results suggest the 
mechanism may be relatively specific to AS160.  In view of the lack of evidence 
implicating sustained kinase activation, a logical alternative is to consider a possible role 
for attenuated dephosphorylation of AS160 by the relevant serine/threonine phosphatases.   
In this context, the current results include the first evidence about the serine/threonine 
phosphatases that regulate AS160 dephosphorylation and also provide unique 
information about the influence of prior exercise on these important enzymes.  Based on 
the results of this study, our working model suggests that the mechanism leading to 
sustained AS160 phosphorylation post-exercise requires regulation by phosphatases by 
means independent of altering the amount of phosphatase catalytic subunits that are 
associated with AS160.   It will be important to investigate mechanisms whereby 
phosphatases may regulate AS160 phosphorylation, independent of association, and to 
determine if phosphatase inhibition contributes to the sustained post-exercise increase in 
AS160 phosphorylation. 
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  AS160 Thr642 AS160 Ser588 
  
Without 
Recombinant 
Phosphatase 
With 
Recombinant 
Phosphatase 
Without 
Recombinant 
Phosphatase 
With 
Recombinant 
Phosphatase 
rPP1 1.00±0.00 0.33±0.06* 1.00±0.00 0.53±0.01* 
rPP2A 1.00±0.00 0.55±0.12* 1.00±0.00 0.62±0.10* 
rPP2B 1.00±0.00 0.73±0.06* 1.00±0.00 0.70±0.12* 
rPP2C 1.00±0.00 0.22±0.04* 1.00±0.00 0.13±0.03* 
 
Table 5.1  
Quantitative values and statistical analysis for results of cell-free AS160 
dephosphorylation assay. AS160 was immunoprecipitated from rat epitrochlearis 
muscles incubated with 5000μU/ml insulin. Immunoblotting with AS160Thr642 and 
AS160Ser588 antibodies results in AS160Thr642 and AS160Ser588 phosphorylation in the 
absence of the phosphatase (Without Recombinant Phosphatase) and was normalized to 
1.00.  Upon incubation with recombinant PP1, PP2A, PP2B, or PP2C (With Recombinant 
Phosphatase), AS160Thr642 and AS160Ser588 phosphorylation was reduced.  Data are 
means ± SE; n = 3-7/group. *P < 0.05 (recombinant phosphatase effect).  rPP1: 
recombinant PP1, rPP2A: recombinant PP2A, rPP2B: recombinant PP2B, rPP2C: 
recombinant PP2C. 
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Figure 5.1  
Rate of 3-O-methylglucose (3-MG) transport in isolated rat epitrochlearis muscles. 
A: rats anesthetized immediately post-exercise (0hPEX) with time-matched sedentary 
controls (0hSED); B: rats anesthetized 3h post-exercise (3hPEX).  For rats in the 0hPEX 
and 0hSED groups, all muscles that were used to measure 3-MG transport were incubated 
without insulin to determine the insulin-independent effect of exercise. For rats in the 
3hPEX groups and sedentary controls (3hSED), one of the paired muscles was incubated 
without insulin, and the contralateral muscle was incubated with 50μU/ml insulin.  A: 
data are means ± SE; n = 8/group. *P < 0.05 (exercise effect, t-test). Open bars, 0hSED; 
filled bars, 0hPEX. B: data are means ± SE; n = 15-16/group. *P < 0.05 (insulin effect, 
post hoc test); †P < 0.05 (exercise effect, post hoc test). In panel B: open bars, without 
insulin; filled bars, with insulin. 
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Figure 5.2  
AS160Thr642 and AS160Ser588 phosphorylation in isolated rat epitrochlearis muscles. 
A-B: rats anesthetized immediately post-exercise (0hPEX) with time-matched sedentary 
controls (0hSED); C-D: rats anesthetized 3h post-exercise (3hPEX). A, C: samples 
immunoblotted for AS160Thr642 phosphorylation; B, D: samples immunoblotted for 
AS160Ser588 phosphorylation. For rats in the 0hPEX and 0hSED groups, all muscles that 
were used to measure AS160 phosphorylation were frozen immediately after dissection 
to determine the insulin-independent effect of exercise. For rats in the 3hPEX groups and 
sedentary controls (3hSED), one of the paired muscles was incubated without insulin, and 
the contralateral muscle was incubated with 50μU/ml insulin.  A-B: data are means ± SE; 
n = 19-24/group. *P < 0.05 (exercise effect, t-test). Open bars, 0hSED; filled bars, 
0hPEX. C-D: data are means ± SE; n = 19–21/group. *P < 0.05 (insulin effect, post hoc 
test); †P < 0.05 (exercise effect, post hoc test). In panels C and D: open bars, without 
insulin; filled bars, with insulin. 
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Figure 5.3 
Immediate post-exercise kinase phosphorylation in isolated rat epitrochlearis 
muscles. Rats anesthetized immediately post-exercise (0hPEX) with time-matched 
sedentary controls (0hSED) and measuring phosphorylation of the following kinases: (A) 
AMPKThr172, (B) AktThr308, (C) RSKSer380, (D) SGKThr256, and (E) p70S6KThr389. All 
muscles that were used to measure kinase phosphorylation were frozen immediately after 
dissection to determine the insulin-independent effect of exercise. A-E: data are means ± 
SE; n = 5-12/group. *P < 0.05 (exercise effect, t-test). 
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Figure 5.4  
Three hour post-exercise kinase phosphorylation in isolated rat epitrochlearis 
muscles. Phosphorylation was measured for the following kinase phospho-sites: (A) 
AMPKThr172, (B) AktThr308, (C) AktSer437, (D) RSKSer380, (E) SGKThr256, and (F) 
p70S6KThr389. For rats in the 3hPEX groups and sedentary controls (3hSED), one of the 
paired muscles was incubated without insulin, and the contralateral muscle was incubated 
with 50μU/ml insulin.  A-F: data are means ± SE; n = 8-12/group. *P < 0.05 (insulin 
effect, post hoc test); †P < 0.05 (exercise effect, post hoc test). Open bars, without 
insulin; filled bars, with insulin. 
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Figure 5.5  
Cell-free dephosphorylation assay of AS160 from insulin-stimulated epitrochlearis 
muscles. AS160 was immunoprecipitated (IP) from rat epitrochlearis muscles incubated 
with 5000μU/ml insulin. Immunoblotting (IB) with AS160Thr642 and AS160Ser588 
antibodies results in AS160Thr642 and AS160Ser588 phosphorylation in the absence of the 
phosphatase.  Upon incubation with recombinant (A) PP1, (B) PP2A, (C) PP2B, or (D) 
PP2C, AS160Thr642 and AS160Ser588 phosphorylation was reduced.  Blots were stripped 
and reprobed with an antibody against Total AS160 to show equal loading.  See Table 5.1 
for a summary of the quantitative (Means ± SE) and statistical analysis of the cell-free 
assays.  IB: immunoblot, IP: immunoprecipitation, rPP1: recombinant PP1, rPP2A: 
recombinant PP2A, rPP2B: recombinant PP2B, rPP2C: recombinant PP2C.  See Table 
5.1 for values and statistical analysis. 
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Figure 5.6  
Effects of prior exercise and insulin incubation on co-immunoprecipitation of AS160 
and phosphatase catalytic subunits. Duplicate epitrochlearis muscle lysate aliquots for 
each sample were loaded in lanes 1-2, 3-4, 5-6, and 7-8. Muscles from duplicate aliquots 
had been treated identically (with/without prior exercise and with/without insulin) except 
for an antibody against total AS160 was present in the immunoprecipitation (IP) cocktail 
for the sample loaded in the odd-numbered lanes (1, 3, 5, 7) and absent for the sample 
loaded in the even numbered lanes (2, 4, 6, 8). An immunoblot of the IP is shown in the 
upper blot. Post-IP supernatant (PIPS) was loaded in a second gel, and an immunoblot of 
the PIPS is shown in the lower blot. Immunoblot with (A) Total AS160, (B) PP1, (C) 
PP2A, (D) PP2B, and (E) PP2C. Lane 9 in panel D is PP2B from 20ug of skeletal muscle 
lysate to show that immunoblotting reveals PP2B in spite of a lack of AS160-PP2B 
association in Lanes 1, 3, 5, and 7.  Ab: antibody, IB: immunoblot, IgG: immunoglobulin 
G, IP: immunoprecipitation. 
 
124 
 
 
 
 
 
 
 
 
 
Figure 5.7  
PP2ATyr307 phosphorylation and PP2ALeu309 methylation in isolated rat 
epitrochlearis muscles. A-B: rats anesthetized immediately post-exercise (0hPEX) with 
time-matched sedentary controls (0hSED); C-D: rats anesthetized 3h post-exercise 
(3hPEX). A, C: samples immunoblotted for PP2ATyr307 phosphorylation; B, D: samples 
immunoblotted for PP2ALeu309 methylation. For rats in the 0hPEX and 0hSED groups, all 
muscles that were used to measure AS160 phosphorylation were frozen immediately after 
dissection to determine the insulin-independent effect of exercise. For rats in the 3hPEX 
groups and sedentary controls (3hSED), one of the paired muscles was incubated without 
insulin, and the contralateral muscle was incubated with 50μU/ml insulin. A-B: data are 
means ± SE; n = 7/group. Open bars, 0hSED; filled bars, 0hPEX. C-D: data are means ± 
SE; n = 8-12/group. For panels C and D: open bars, without insulin; filled bars, with 
insulin. 
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CHAPTER VI 
 
DISCUSSION 
 
Focus of this Discussion  
 This chapter of the dissertation will: 1) summarize the key findings from the three 
studies; 2) identify some questions raised by the results of Studies 1 and 2 and propose 
general future directions to take with those studies; 3) identify some questions raised by 
the results of Study 3; 4) provide an integrated interpretation of the results of Studies 1, 2, 
and 3; 5) provide a brief proposal of possible future experiments related to Study 3; and 
6) provide overall conclusions. 
  
 
Summary of Key Findings  
 Results from Studies 1 and 2 of the dissertation, which focused on the role of the 
Kallikrein Kininogen System (KKS) in understanding the mechanisms associated with 
the post-exercise increase in insulin-stimulated glucose transport, extended the initial in 
vitro observations with electrically stimulated isolated skeletal muscles (7) by 
investigating the KKS from an in vivo physiological standpoint (28, 29).   This was 
accomplished using two separate genetic models: mice with a genetic knockout of the B2 
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receptor of bradykinin (B2RKO) and rats with a naturally occurring deficiency in 
kininogen (BNK).   
 Results from Study 3 of the dissertation provided more insight into the 
mechanisms that regulate the sustained increase in AS160 phosphorylation after acute 
exercise, specifically regarding the kinases and phosphatases that participate.  Kinases 
were evaluated by studying epitrochlearis muscles from rats using an exercise protocol 
known to result in sustained phosphorylation of AS160.  Phosphatases were evaluated 
using this same protocol as well as by employing cell-free dephosphorylation assays and 
co-immunoprecipiation of AS160 with the phosphatases.   
 
Study 1: The B2 receptor of bradykinin is not essential for the post-exercise increase in 
glucose uptake by insulin-stimulated mouse skeletal muscle 
Study 1 used genetically modified mice null for the B2 receptor (B2R) to test the 
idea that this receptor may be important for the post-exercise increase in insulin action.  
Isolated soleus and EDL muscles from B2RKO and wildtype (WT) control mice that had 
previously undergone acute exercise (EX) or remained sedentary (SED) were incubated 
in a solution without or with a physiological dose of insulin.  The insulin-stimulated 
increase in glucose uptake (delta insulin) calculated by subtracting the basal values from 
the insulin-stimulated values was also determined.  Insulin-stimulated muscles from 
Experiment 1 were incubated in 60µU/ml insulin, and insulin-stimulated muscles from 
Experiment 2 muscles were incubated in 100µU/ml insulin. 
Genotype Effects of Muscle Glucose Uptake 
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• Soleus glucose uptake without insulin was not different between 
genotypes. 
• EDL glucose uptake without insulin was not different between genotypes. 
• Soleus glucose uptake with insulin tended to be lower for B2RKO vs. WT 
mice with 60µU/ml insulin, was significantly lower for B2RKO vs. WT 
mice with 100µU/ml insulin, and was significantly lower for B2RKO vs. 
WT mice when pooling samples incubated with 60µU/ml and 100µU/ml 
insulin.  
• EDL glucose uptake with insulin was not different between genotypes 
• Soleus delta insulin was significantly lower for B2RKO vs. WT mice with 
60µU/ml insulin, 100µU/ml insulin, and when data from both experiments 
were pooled. 
• EDL delta insulin was not different between genotypes. 
Exercise Effects of Muscle Glucose Uptake 
• Soleus glucose uptake without insulin tended to be greater for EX vs. SED 
mice in Experiment 1, tended to be greater for EX vs. SED mice in 
Experiment 2, and was significantly greater for EX vs. SED mice when 
pooling samples from both experiments. 
• EDL glucose uptake without insulin was not different between EX and 
SED mice. 
•  Soleus glucose uptake with insulin tended to be to be greater for EX vs. 
SED mice with 60µU/ml, was significantly greater for EX vs. SED mice 
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with 100µU/ml insulin, and was significantly greater for EX vs. SED mice 
when pooling samples incubated with 60µU/ml and 100µU/ml insulin. 
• EDL glucose uptake with insulin was not different between EX and SED 
mice. 
• Soleus delta insulin tended to be greater for EX vs. SED mice with 
60µU/ml, tended to be greater for EX vs. SED mice with 100µU/ml 
insulin, and was significantly greater for EX vs. SED mice when pooling 
samples incubated with 60µU/ml and 100µU/ml insulin. 
• EDL delta insulin was not different between EX vs. SED mice. 
Interactions of Genotype and Exercise of Muscle Glucose Uptake 
• There were no statistically significant interactions between genotype 
(B2RKO vs. WT) and exercise (EX vs. SED) for any of the muscle 
glucose uptake measurements. 
AktThr308 Phosphorylation 
• Soleus and EDL AktThr308 phosphorylation were not significantly different 
with genotype or exercise, with or without insulin, or delta insulin.  
 
Study 2: Post-exercise skeletal muscle glucose transport is normal in kininogen-deficient 
rats 
Study 2 used rats used BNK to determine if normal circulating kininogen levels 
are required for the sustained increase in insulin-stimulated glucose transport in skeletal 
muscle after exercise.  Isolated epitrochlearis muscles from BNK and Brown Norway 
(BN) control rats that had previously undergone acute exercise (3hPEX) or remained 
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sedentary (3hSED) were incubated in a solution without or with a physiological dose of 
insulin.  The insulin-stimulated increase in glucose uptake (delta insulin) calculated by 
subtracting the basal values from the insulin-stimulated values was also determined.  
Furthermore, this study evaluated the insulin-independent effect of exercise on skeletal 
muscle glucose transport comparing muscles from rats of each genotype that had been 
dissected immediately post-exercise (0hPEX) or were time-matched sedentary controls 
(0hSED).   
Genotype Effects of Muscle Glucose Transport 
• Epitrochlearis glucose transport without insulin was not different between 
BNK and BN rats. 
• Epitrochlearis glucose transport with 60µU/ml insulin was not different 
between BNK and BN rats. 
• Epitrochlearis delta insulin was not different between BNK and BN rats. 
Exercise Effects of Muscle Glucose Transport 
• Epitrochlearis glucose transport without insulin was significantly greater 
in 3hPEX vs. 3hSED rats.   
• Epitrochlearis glucose transport with 60µU/ml insulin was significantly 
greater in 3hPEX vs. 3hSED rats.   
• Epitrochlearis delta insulin was significantly greater in 3hPEX vs. 3hSED 
rats.   
Interactions of Genotype and Exercise of Muscle Glucose Uptake 
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• There were no statistically significant interactions between genotype 
(BNK vs. BN) and exercise (3hPEX vs. 3hSED) for any of the muscle 
glucose transport measurements. 
Insulin-Independent Effects 
• There was no difference in BNK vs. BN rats for the exercise-induced 
increase in insulin-independent glucose transport. 
• There was a significant increase in glucose transport  in 0hPEX rats vs. 
0hSED rats in both BN and BNK rats. 
• Muscle glycogen and AMPKThr172 phosphorylation were not different in 
BNK vs. BN rats.  
• Muscle glycogen was significantly reduced and AMPKThr172 
phosphorylation was significantly increased in 0hPEX vs. 0hSED to a 
similar extent in both BNK and BN rats. 
 
Study 3: Mechanisms for the prolonged post-exercise increase in AS160 
phosphorylation: Roles of protein kinases and phosphatases 
Study 3 used epitrochlearis muscles from Wistar rats that had undergone an 
exercise protocol known to result in sustained AS160 phosphorylation and other 
experiments required immunoprecipitated AS160 from rat epitrochlearis muscle.  There 
were three overall goals: 1) To establish if AS160Ser588 phosphorylation was sustained 
post-exercise, 2) To evaluate the known kinases of AS160 to determine if greater 
phosphorylation of these kinases is found after prior exercise, and 3) To conduct the first 
known investigation of the phosphatases that regulate AS160 dephosphorylation. 
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 AS160 Phosphorylation 
• AS160Ser588
• AS160
 phosphorylation was increased immediately post-exercise, and 
greater phosphorylation was sustained three hours post-exercise in rat 
epitrochlearis muscle.  This phospho-site has been reported to be one of 
the two most important sites for insulin-stimulated GLUT4 translocation 
(27). 
Thr642
Kinases 
 phosphorylation was confirmed to be increased immediately 
post-exercise, and greater phosphorylation was sustained three hours post-
exercise in rat epitrochlearis muscle, and this phospho-site has been 
reported to be one of the two most important sites for insulin-stimulated 
GLUT4 translocation (27). 
• The four known kinases of AS160 (Akt, AMPK, RSK, and SGK) did not 
have greater phosphorylation on phospho-sites known to be essential for 
increased enzyme activation in muscles from rats that had undergone 
exercise three hours prior versus sedentary controls. 
• Another possible AS160 kinase based on consensus motifs, p70S6K, did 
not have greater phosphorylation on a phospho-site known to be essential 
for its function in rats that had undergone exercise three hours prior versus 
sedentary controls. 
• Of the 5 studied kinases, only AMPK had greater phosphorylation 
immediately post-exercise vs. sedentary control rats. 
Phosphatases 
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• PP1, PP2A, PP2B, and PP2C had the ability to dephosphorylate AS160 on 
the Thr642 and Ser588 phospho-sites of rat epitrochlearis muscle in a cell-
free assay. 
• PP1 and PP2C were specifically associated with AS160 from rat 
epitrochlearis muscles based on results from co-immunoprecipitation. 
• PP2A and PP2B were not found to have specific association with AS160 
from rat epitrochlearis muscle based on results from co-
immunoprecipitation. 
• PP2ATyr307
• PP2A
 phosphorylation in rat epitrochlearis muscle was not altered by 
prior exercise or incubation with physiological insulin.   
Leu309
• PP2A
 methylation in rat epitrochlearis muscle was not altered by 
prior exercise or incubation with physiological insulin.  
Tyr307 phosphorylation and PP2ALeu309
•  The amount of PP1, PP2A, PP2B, and PP2C association with AS160 as 
measured by co-immunoprecipitation was not altered by prior exercise or 
incubation with physiological insulin. 
 methylation was not altered 
immediately post-exercise vs. time-matched sedentary controls. 
 
 
Future Directions for Studies 1 and 2 
Results from Studies 1 and 2 of the dissertation did not support the idea that the 
KKS is essential for the post-exercise increase in insulin-stimulated glucose transport in 
skeletal muscle.  There are several caveats of this interpretation.  In Study 1, it is 
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conceivable that the B1 receptor of bradykinin (B1R) may be compensating for the lack 
of B2R in B2RKO mice.  It has been reported that mRNA of B1R is greater in B2RKO 
mice vs. WT (6).  Because skeletal muscle abundance of B1R protein in B2RKO has not 
been reported, we obtained the only available antibodies for B1R from Alomone Labs 
and from Dr. Werner Müller-Esterl, a bradykinin researcher at the University of Frankfurt.  
However, repeated experiments using the B1R antibody revealed multiple bands that 
defied interpretation.  Regardless, it is important to note that B2RKO mice are insulin 
resistant (6), indicating that B1R is unable to replace the essential role of B2R for normal 
insulin sensitivity.   In Study 2, plasma kininogen values of BNK rats have been reported 
to be less than 1% of the normal plasma values for Brown Norway (BN) rats (24).  
Accordingly, it remains formally possible that this very low amount of kininogen in BNK 
rats may be sufficient to trigger increases in skeletal muscle insulin sensitivity post-
exercise.   
It is also important to note that following completion of Studies 1 and 2, it was 
discovered that in vivo exercise and in vitro contractions performed in serum may not 
lead to increased insulin-stimulated glucose transport by an identical mechanism (9).  
Funai et al. (9) found that when in vivo exercise is followed by rapid removal of the 
epitrochlearis and in vitro contraction of the isolated muscle, the two stimuli induced an 
additive effect on the subsequent increase in insulin-stimulated glucose transport.  These 
results suggested that the increase in insulin-stimulated glucose transport induced after in 
vitro contraction and after in vivo exercise may be caused by distinct mechanisms.  This 
finding can serve to reconcile the evidence supporting KKS’s involvement in the post-
contraction increase in insulin-stimulated glucose transport in an in vitro model (7) with 
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the lack of evidence supporting the KKS’s involvement in the post-exercise increase in 
insulin-stimulated glucose transport in in vivo models in Studies 1 and 2.  
Although the results of Studies 1 and 2 do not support a role for the KKS as a 
possible trigger for increased insulin-stimulated glucose transport after in vivo exercise, 
there would still be value in understanding the mechanisms that lead to increased insulin-
stimulated glucose transport after in vitro contractions in serum.  In this context, it would 
be useful to consider new candidate proteins found in the serum that may be essential for 
the development of post-contraction increase in skeletal muscle insulin sensitivity.   New 
possibilities may come from a repository of candidates of a new and relatively unstudied 
area in skeletal muscle physiology, myokines.  Myokines are cytokine-like proteins 
secreted from skeletal muscle that may be responsible for bioeffects on target tissues (22, 
23).  There are over 600 known myokines (13) that can be screened for the characteristics 
the serum factor is likely to contain: 1) it should be regulated by muscle contractions, 2) 
it should improve insulin sensitivity, and 3) it should be composed of proteins greater 
than 10 kDa.   
The following questions that are raised from Studies 1 and 2 which could guide 
future research: 
1) Is the post-exercise increase in insulin-stimulated glucose uptake of muscle 
found in B2RKO mice attributable to a compensatory effect of greater B1R in 
the skeletal muscle of B2RKO mice? 
2) Is the relatively low amount of circulating plasma kininogen in BNK rats 
compared to BN rats, sufficient to increase skeletal muscle insulin sensitivity 
after exercise? 
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3) If questions 1 and 2 do not implicate the KKS, what other candidate proteins 
in the serum are responsible for triggering the in vitro contraction increase in 
insulin-stimulated glucose transport with serum retained? 
4) Are one or multiple myokines essential for elevated insulin-stimulated glucose 
transport in skeletal muscle after in vitro contraction in serum and is this also 
necessary for elevated insulin-stimulated glucose transport after in vivo 
exercise? 
 
 
Future Directions for Study 3 
 Results from Study 3 of the dissertation have provided more insight in the 
mechanisms that regulate sustained AS160 phosphorylation after exercise.  Because the 
results of Study 3 did not provide evidence implicating the known AS160 kinases as 
being responsible for sustained AS160 phosphorylation after exercise, serine/threonine 
protein phosphatases were investigated.   These experiments demonstrated that each of 
the four most abundant skeletal muscle phosphatases (PP1, PP2A, PP2B, and PP2C) were 
all shown to dephosphorylate AS160 in cell-free conditions.  However, catalytic subunits 
of PP1 and PP2C, but not PP2A or PP2B, were shown to specifically associate with 
AS160.  The amount of association of these phosphatases to AS160 was not altered by 
prior exercise or insulin incubation.  Based on current evidence, PP1 and PP2C appear to 
be the leading candidates for regulating AS160 dephosphorylation on Thr642 and Ser588, 
but it is uncertain if they have redundant, complementary, or independent actions on 
AS160 phosphorylation status.  Ultimately, it will be important to study both their 
142 
 
separate and combined roles, but as a practical matter, I will first focus on PP1
1) What is/are the specific PP1 regulatory subunit(s) linking the PP1 catalytic 
subunit to AS160 in skeletal muscle? 
 for 
recommended future research because there is a more extensive scientific literature base 
and more readily available reagents to study PP1 vs. PP2C.  The results of Study 3 raise 
many general questions with regards to AS160 phosphatases, specifically PP1: 
2) Does the PP1 regulatory subunit associated with AS160 in skeletal muscle 
regulate the activity of PP1 catalytic subunit and therefore AS160 
dephosphorylation?  
3) Does altering the expression of the PP1 regulatory subunit associated with 
AS160 alter insulin-stimulated AS160 phosphorylation or AS160 
phosphorylation post-exercise in skeletal muscle? 
4) Does altering the expression of the PP1 regulatory subunit associated with 
AS160 alter post-exercise insulin-stimulated glucose transport? 
5) Are there any endogenous inhibitors of the catalytic subunit of PP1? 
6) Is the activity of the inhibitors of the catalytic subunit of PP1 altered with 
prior exercise or insulin incubation? 
Because current results are consistent with the idea that PP1 inhibition results in 
sustained AS160 phosphorylation, it will be important to design future studies to 
demonstrate if this model is valid.   
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Integrated Interpretation of the Results of Studies 1, 2, and 3 
The three studies in this dissertation were each related to specific aspects of the 
mechanisms whereby acute exercise results in a sustained effect on skeletal muscle 
glucose transport.  Studies 1 and 2 addressed the role of the KKS for the post-exercise 
increase in insulin-stimulated glucose uptake, and Study 3 investigated the mechanisms 
whereby protein kinases and phosphatases contributed to sustained AS160 
phosphorylation post-exercise.   
Figure 6.2 illustrates a simple model for the series of steps that account for the 
post-exercise increase in insulin-stimulated glucose transport in skeletal muscle.  The 
model includes four components (triggers, memory elements, mediators, and the end-
effector) that lead from prior exercise to the ultimate outcome of increased insulin-
stimulated glucose transport.  The progression of steps for the post-exercise increase in 
insulin-stimulated glucose transport includes: 1) triggers that are initiating events that 
activate the next component. 2) The second component is called a memory element, and it 
provides a persistent mechanism for coupling triggers to the subsequent component.  3) 
This next component is called a mediator, and it regulates the function of the final 
component. 4) The last component is designated the end-effector, and it performs the 
final action (i.e., increased insulin-stimulated glucose transport).   
The time-course associated with each of the components in relationship to the 
exercise is also included in the figure.  In addition, the figure indicates candidates for 
bioeffects corresponding to particular components of the model that were assessed in this 
dissertation.  Finally, the figure also indicates if the results of the experiments were 
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supportive or not supportive of each of the respective candidate bioeffects that were 
tested.   
For these components in our model for the post-exercise increase in insulin-
stimulated glucose transport, it is well-established that increased cell surface GLUT-4 is 
an end-effector accounting for increased insulin-stimulated glucose transport (12, 33).  
For prior exercise to lead to increased insulin-stimulated glucose transport, exercise must 
trigger something to initiate the series of events.  Furthermore, the muscle needs to 
“remember” that it had exercised several hours or even days prior. Therefore, some form 
of memory element must be present in order to allow mediators to affect the effector.  
Physiological insulin must regulate these mediators and effectors in order to lead to 
increased insulin-stimulated glucose transport after exercise.   
Using two different animal models (mice and rats) to study two different 
components of the KKS (B2R and plasma kininogen), results from Study 1 and Study 2 
argued against KKS as an essential trigger for the post-exercise increase in insulin 
sensitivity in skeletal muscle.  The original hypothesis implicating KKS as a necessary 
trigger came from in vitro contraction studies that implicated a “serum factor” being 
necessary for the post-contraction increase in insulin-stimulated glucose transport in 
skeletal muscle as contraction of the muscle in serum versus contraction in a buffer 
solution results in a greater insulin-stimulated increase in glucose transport (4, 11). 
However, recent data revealed that in vivo exercise and in vitro contraction in rat serum 
versus either stimuli alone additively elevated the subsequent increase in glucose 
transport in skeletal muscle (9).  These data suggest that the mechanisms leading to the 
post-exercise increase in insulin-stimulated glucose transport in skeletal muscle may be 
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different from the mechanisms leading to the post-contraction increase in insulin-
stimulated glucose transport in skeletal muscle.  Therefore, KKS may be an essential 
trigger for the post-contraction increase in insulin-stimulated glucose transport, but as 
described in Studies 1 and 2, it is not an essential trigger for the post-exercise increase in 
insulin-stimulated glucose transport in skeletal muscle.   
Notably, the results in Study 3 indicated that AMPK is a top candidate for a 
trigger as evidenced by this protein being the only known AS160 kinase with increased 
AMPKThr172 phosphorylation immediately after exercise on a phospho-site essential for 
its activity concomitant with increased AS160Thr642 and AS160Ser588 phosphorylation 
immediately after exercise.  Furthermore in Study 3, the results indicated that in addition 
to sustained phosphorylation of the AS160Thr642 phospho-site, AS160Ser588 
phosphorylation is also sustained after exercise suggesting that this is also a strong 
candidate for a memory element/mediator.  The evidence did not implicate the known 
AS160 kinases for sustained AS160 phosphorylation, but studies of serine/threonine 
phosphatases revealed two top candidate AS160 phosphatases (PP1 and PP2C) that can 
control AS160 dephosphorylation and associate with AS160 in skeletal muscle.  Future 
research built on the foundation of the results of Study 3 can test new hypotheses related 
to the possible roles of PP1 and/or PP2C in the sustained exercise effect on AS160 
phosphorylation.  These future studies can evaluate the possibility that sustained AS160 
phosphorylation acts as a memory element/mediator and test how sustained AS160 
phosphorylation might contribute to the end-effector, increased cell-surface GLUT4, 
resulting in increased insulin-stimulated glucose transport. 
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Proposal for Future Research  
 The results of this dissertation were used to develop the brief proposal for future 
research that is found below.  The proposal focuses on the possible role of PP1 in the 
regulation of AS160 dephosphorylation. 
Studying the function of PP1 on specific target substrates is a challenge as PP1 is 
a highly abundant phosphatase in skeletal muscle that is associated with many target 
substrates.  Regulation of PP1 activity can occur via 2 primary mechanisms: 1) changes 
in the activity of the catalytic subunit whose inhibitory proteins is altered by 
phosphorylation (a more detailed explanation is below) and 2) modulation of the PP1 
regulatory subunit by mechanisms described below.  The few known catalytic subunits of 
PP1 are bound to a diverse number of regulatory subunits (over 100 have been identified) 
that provide substrate specificity and subcellular localization (31).  These PP1 regulatory 
subunits can, in turn, bind and be regulated by other proteins (21, 34) or can be regulated 
by post-translational modifications of the regulatory subunit (17) resulting in alterations 
in PP1’s phosphatase activity.  
Specific Aims 
As none of the regulatory subunit(s) of PP1 localized to AS160 have been 
identified, it will be important to discover the identity of such proteins (via methods such 
as mass spectrometry) to determine if a specific PP1 regulatory subunit(s) associates with 
AS160 in vivo.   
 
Specific Aim 1: Identify the specific PP1 regulatory subunit(s) associated with AS160 
(PP1reg-AS160) from rat epitrochlearis muscle. 
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Hypothesis 1A: Mass spectrometry analysis will reveal a single PP1 regulatory 
subunit that is associated with AS160 and is a promising candidate to be the PP1reg-
AS160. 
 If results from Specific Aim 1, reveal a promising candidate, then further analysis 
of this protein as a regulator of AS160 dephosphorylation will be performed as described 
below for Specific Aims 2 and 3.  If results from Specific Aim 1, do not reveal
 
 a 
promising candidate for the PP1 regulatory subunit, Specific Aims 4, 5, and 6 can still be 
conducted to study regulation at the site of the PP1 catalytic subunit.   
Specific Aim 2: Determine if the overexpression of the PP1 regulatory subunit associated 
with AS160 (PP1reg-AS160) regulates AS160 dephosphorylation by PP1.  
Hypothesis 2: Rats transfected with DNA for PP1reg-AS160 in epitrochlearis 
muscle (versus the contralateral muscle transfected with an empty vector) will have 1) 
greater abundance of PP1reg-AS160, 2) greater association of PP1reg-AS160 with 
AS160 (via co-immunoprecipitation), 3) greater association of PP1reg-AS160 with the 
PP1 catalytic subunit (PP1cat), 4) decreased AS160Thr642 and AS160Ser588 
phosphorylation after incubation with insulin , and 5) a more rapid time course for 
reversal of AS160Thr642 and AS160Ser588 phosphorylation after transient incubation with 
physiological insulin. 
 
Specific Aim 3: Determine if the reduction of expression of the PP1 regulatory 
subunit associated with AS160 (PP1reg-AS160) regulates AS160 dephosphorylation by 
PP1.  
148 
 
Hypothesis 3: Rats transfected with siRNA targeting PP1reg-AS160 in 
epitrochlearis muscle (versus the contralateral muscle transfected with an empty vector) 
will have 1) reduced abundance of PP1reg-AS160, 2) reduced association of PP1reg-
AS160 with AS160 (via co-immunoprecipitation), 3) reduced association of PP1reg-
AS160 with the PP1cat, 4) increased AS160Thr642 and AS160Ser588 phosphorylation after 
incubation with insulin , and 5) a more prolonged time course for reversal of AS160Thr642 
and AS160Ser588 phosphorylation after transient incubation with physiological insulin. 
If results from Specific Aim 2 and 3 support PP1’s role as a phosphatase of 
AS160, follow up studies can examine the specific mechanisms by which PP1 functions 
(via regulation of Inhibitor-1 and/or Inhibitor 2; see Specific Aim 4).  If results from 
Specific Aim 2 do not support
As described above, the phosphatase activity of PP1 is also regulated by the 
activation of binding proteins to the PP1 catalytic subunit.  Several endogenous inhibitory 
proteins such as Inhibitior-1 (Inh-1), Inhibitor-2 (Inh-2), 
 PP1’s role as a phosphatase of AS160, similar studies will 
be performed on PP2A, PP2B, or PP2C based on results of the mass spectrometry 
analysis from Specific Aim 1.   
protein kinase C (PKC)-
dependent phosphatase inhibitor of 17kDa (CPI-17), and Dopamine- and cAMP-
regulated phosphoprotein of 32 kDa (DARPP-32) have been reported to, upon activation, 
bind and inhibit PP1 phosphatase activity (31).  While DARPP-32 is most abundant in 
neuronal tissue and CPI-17 is abundant in smooth muscle, Inh-1 and Inh-2 are abundant 
in skeletal muscle (18, 19, 32).  Inhibition of PP1 by Inh-1 requires phosphorylation of 
either Thr35 or Ser67 site of Inh-1 (8, 14, 15, 25).  Inhibition of PP1 by Inh-2 requires 
phosphorylation of Thr72 primarily, and phosphorylation of Ser86 of Inh-2 enhances the 
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rate of Inh-2Thr72
Inh-1 and Inh-2 proteins are also attractive targets for analysis because they 
provide a logical, simple mechanism in which prior exercise could result in PP1 
inhibition thereby leading to the sustained increase in AS160 phosphorylation after 
exercise.   
 phosphorylation (20, 35).  Various kinases have been identified to 
phosphorylate each phospho-site of Inh-1 and Inh-2, independently.  It will therefore be 
important to assess if inhibitory proteins targeting the catalytic subunit also regulate PP1-
bound AS160 function. 
 
Specific Aim 4: Determine if PP1 inhibitory proteins regulate sustained AS160 
phosphorylation three hours after exercise via PP1 catalytic subunit inhibition. 
Hypothesis 4A: Inh-1 associated with PP1-AS160 will have increased 
phosphorylation on Thr35 and/or Ser67 in isolated rat epitrochlearis muscles immediately 
and three hours post-exercise in the absence of insulin. 
Hypothesis 4B: Inh-2 associated with PP1-AS160 will have increased 
phosphorylation on Thr72 and/or Ser86 in isolated rat epitrochlearis muscles immediately 
and three hours post-exercise in the absence of insulin. 
Hypothesis 4C: Inh-1 and Inh-2 phosphorylation in isolated rat epitrochlearis 
muscles will not be altered when incubated with physiologic insulin versus without 
insulin (with or without prior exercise). 
If results from Specific Aim 4 support the role of Inh-1 and/or Inh-2 as an 
inhibitor of PP1 activity after prior exercise, the roles of Inh-1 and/or Inh-2 will be 
further examined to see if modulating the phosphorylation/activation state of these 
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proteins results in altered PP1 inhibition and therefore sustained AS160 phosphorylation.  
If results from Specific Aim 4 do not support the role Inh-1 and/or Inh-2 as an inhibitor 
of PP1 activity after prior exercise, regulation of the activity of other phosphatase(s) of 
AS160 can be examined, such as the other top candidate, PP2C. 
As Inh-1 and Inh-2 are homogenous proteins that can target PP1 catalytic subunits 
on skeletal muscle proteins not regulating AS160, altering PP1-AS160-specific Inh-
1/Inh-2 proteins presents a challenge.  To minimize systemic effects and localize the 
mutation to a single muscle, vector DNA developed with mutated Inh-1/Inh-2 proteins 
will be electroporated into rat epitrochlearis muscle (the contralateral epitrochlearis 
muscle will be electroporated with empty vector and serve as a control).  Rats will then 
be exercised to see if muscles expressing the phospho-mutants no longer have sustained 
AS160 phosphorylation. 
 
Specific Aim 5: Determine if overexpressing phospho-mutants of Inh-1 and/or Inh-2 in 
the rat epitrochlearis muscle results in the impairment of the sustained increase in AS160 
phosphorylation three hours after exercise. 
Hypothesis 5: Electroporating DNA vectors of Inh-1/Inh-2 with mutations (via 
alanine substitution) of the phospho-sites essential for its activity into the rat 
epitrochlearis will result in the elimination of sustained AS160 phosphorylation three 
hours after exercise. 
If results from Specific Aim 4, reveal that AS160 phosphorylation is no longer 
sustained three hours post-exercise, in the genetically modified muscles, the post-exercise 
increase in insulin-stimulated glucose transport skeletal muscle glucose will be assessed 
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to determine if sustained AS160 phosphorylation after exercise is essential for this 
functional outcome.  We will also assess other relevant proteins (GLUT4 abundance, 
amount of other serine/threonine phosphatases associated with AS160, activation states 
of kinases, etc.) to monitor for potential compensatory or indirect effects of phospho-
mutants. 
 
Specific Aim 6: Determine if overexpressing mutated Inh-1 and Inh-2 results in the 
impairment of the post-exercise increase in insulin-stimulated glucose transport in rat 
skeletal muscle. 
 Hypothesis 6: Mutations of Inh-1/Inh-2 phospho-sites in rat epitrochlearis muscle 
(via electroporation of DNA containing alanine substitutions) will have reduced glucose 
transport post-exercise with a physiological insulin concentration vs. empty vector 
controls. 
 
Research Design and Methods 
Research Protocol  
 Specific Aim 1: AS160 will be immunoprecipitated from rat epitrochlearis lysate 
and prepared for mass spectrometry.  The mass spectrometry analysis will provide a list 
of candidate proteins associated with AS160 that can be assessed to determine if any of 
the PP1 regulatory subunit(s) are associated with AS160.   
 Specific Aim 2: PP1reg-AS160 DNA vectors will be obtained or isolated from rat 
DNA via PCR.  These vectors will be heat-shocked into competent cells, grown en masse 
in E. Coli cells, and a commercially available DNA preparation kit will be used to isolate 
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a large quantity of pure DNA from the cells.  This DNA containing PP1reg-AS160 will 
be electroporated into one epitrochlearis muscle of male Wistar rats (6-8 weeks old) and a 
sham electroporation transfection (using empty vector) will be performed in the 
contralateral muscle as previously described (2, 3, 5).   The epitrochlearis muscles from 
these rats will be dissected and split into two longitudinal muscle strips with one strip 
being incubated in a solution with physiological insulin and the other being incubated in a 
solution without insulin.  The muscles will then be frozen and assessed for PP1reg-
AS160 abundance, AS160 and PP1reg-AS160 association, PP1cat-PP1reg-AS160 
association, and AS160Thr642 and AS160Ser588 phosphorylation will be measured using 
immunoprecipitation and immunoblotting.  The procedure of the time course of the 
reversal of AS160Thr642 and AS160Ser588 phosphorylation after transient physiological 
insulin incubation will be conducted as previously described (30). 
 Specific Aim3: PP1reg-AS160 siRNA would be generated either by purchasing 
from a manufacturer or constructing one using a kit (26).  The PP1reg-AS160 siRNA will 
be electroporated into one epitrochlearis muscle in of male Wistar rats (6-8 weeks old) 
and a sham electroporation transfection (using empty vector) will be performed in the 
contralateral muscle as previously described (1, 16).   The epitrochlearis muscles from 
these rats will be dissected and split into two longitudinal muscle strips with one strip 
being incubated in a solution with physiological insulin and the other being incubated in a 
solution without insulin.  The muscles will then be frozen and assessed for PP1reg-
AS160 abundance, AS160 and PP1reg-AS160 association, PP1cat-PP1reg-AS160 
association, and AS160Thr642 and AS160Ser588 phosphorylation will be measured using 
immunoprecipitation and immunoblotting.  The procedure of the time course of the 
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reversal of AS160Thr642 and AS160Ser588 phosphorylation after transient physiological 
insulin incubation will be conducted as previously described (30). 
Specific Aim 4: Male (6-8 week old) Wistar rats will be assigned to either remain 
sedentary or to perform a swimming exercise protocol (10, 28) that is known to result in 
sustained AS160 phosphorylation after exercise.  Following exercise, the rats will be 
returned to their cage for three hours without access to food.  The rats that had exercised 
and time-matched sedentary controls will be anesthetized and their epitrochlearis muscles 
will be dissected and contra-lateral muscles will being incubated in a solution with or 
without a physiologic dose of insulin (50μU/ml).  Muscles from another cohort of rats 
will be dissected immediately after exercise.  The muscles from both time points will 
then be frozen and AS160 will be immunoprecipitated and then immunoblotted to assess 
phosphorylation of Inh-1 and Inh-2 using commercially available antibodies to specific 
phospho-sites of these proteins.   
Specific Aim 5: Inh-1/Inh-2 DNA vectors will be obtained or isolated from rat 
DNA via PCR.  Primers containing point mutations of the specific serine/threonine 
residues (to alanine) will be developed and used to amplify mutated Inh-1 and Inh-2 
constructs via PCR.  These vectors will be heat-shocked into competent cells, grown en 
masse in E. Coli cells, and a commercially available DNA preparation kit will be used to 
isolate a large quantity of pure DNA from the cells.  This DNA containing mutated forms 
of Inh-1/Inh-2 will be electroporated into one epitrochlearis muscle of male Wistar rats 
(6-8 weeks old) and an electroporation transfection will be performed in the contralateral 
muscle with empty vector.  After recovery, these rats will be assigned to either remain 
sedentary or to perform a swimming exercise protocol (10, 28) that is known to result in 
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sustained AS160 phosphorylation after exercise.  Following exercise, the rats will be 
returned to their cage for three hours without access to food.  The rats that had exercised 
and time-matched sedentary controls will be dissected, frozen, and AS160 will be 
immunoprecipitated and then immunoblotted to assess phosphorylation of Inh-1 and Inh-
2 using commercially available antibodies to specific phospho-sites of these proteins.   
Specific Aim 6:  The same protocol will be used as described in Specific Aim 4, 
except that epitrochlearis muscles (the transfected and empty vector transfected muscle) 
will be split into two longitudinal muscle strips with one strip being incubated in a 
solution with physiological insulin and the other being incubated in a solution without 
insulin.   After incubation of the skeletal muscles in insulin, those muscles will be 
subsequently incubated for the measurement of 3-methylglucose transport and then 
frozen.   
 
Interpretation 
 Specific Aim 1:  If mass spectrometry analysis of immunoprecipitated AS160 
reveals a PP1reg-AS160 candidate, this would suggest that PP1 is a specific phosphatase 
of AS160.  If no PP1reg-AS160 candidates are found, this would suggest that PP1 is 
either not a phosphatase of AS160 or that the conditions in which AS160 was 
immunoprecipitated resulted in disassociated PP1reg-AS160. 
Specific Aim 2: If overexpression of PP1reg-AS160 in rat epitrochlearis muscle is 
accompanied by all of the predicted effects, it would be strong evidence that the PP1reg -
AS160 is an important determinant of AS160 dephosphorylation by PP1. 
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If successful overexpression of PP1reg-AS160 resulted in increased PP1reg-
AS160 abundance, association with AS160, and association with PP1cat, but did not 
result in reduced phosphorylation of AS160 or a more rapid time course of reversal, the 
hypothesis would not be supported and suggest that AS160 dephosphorylation is not 
dependent on increased PP1 abundance (via PP1reg-AS160 overexpression). 
Specific Aim 3: If reduced expression of PP1reg-AS160 in rat epitrochlearis 
muscle is accompanied by all of the predicted effects, it would be strong evidence that the 
PP1-reg-AS160 is an important determinant of AS160 dephosphorylation by PP1.   
If reduced expression of PP1reg-AS160 that resulted in decreased PP1reg-AS160 
abundance, association with AS160, and association with PP1cat, but did not result in 
increased phosphorylation of AS160 or a prolonged rapid time course of reversal, the 
hypothesis would not be supported and suggest that AS160 dephosphorylation is not 
dependent on PP1 (via PP1reg-AS160 reduction), there is compensation from another 
phosphatase, or that the degree of phosphorylation of AS160 that occurs in normally 
expressing PP1reg-AS160 has already reached an upper physiological limit (i.e. more 
AS160 proteins cannot be phosphorylated).   
Specific Aim 4: If phosphorylation of Inh-1Thr35, Inh-1Ser67, Inh-2Thr72, and/or Inh-
2Ser86 from immunoprecipitated AS160 from rat skeletal muscle are increased after prior 
exercise, the hypothesis would be supported suggesting that PP1’s phosphatase activity is 
inhibited concomitant with sustained AS160Thr642 and AS160Ser588 phosphorylation.  This 
would support the working model that sustained AS160 phosphorylation results from PP1 
inhibition by Inh-1 and/or Inh-2.  If phosphorylation of these proteins is not altered with 
prior exercise, this would suggest that PP1 inhibition of AS160 occurs via an Inh-1 and 
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Inh-2 phosphorylation independent mechanism.  Additionally, if these increases in 
phosphorylation of Inh-1 and Inh-2 after exercise occur independent of insulin, this would 
suggest that insulin-stimulation does not regulate Inh-1 and Inh-2 phosphorylation. 
Specific Aim 5: If mutating Inh-1/Inh-2 phospho-sites results in diminished 
skeletal muscle AS160Thr642 and AS160Ser588 phosphorylation after exercise, the 
hypothesis would be supported and suggests that inhibiting PP1 phosphatase activity on 
AS160 abolishes the sustained phosphorylation of AS160 post-exercise. If mutating Inh-
1/Inh-2 phospho-sites does not diminish skeletal muscle AS160Thr642 and AS160Ser588 
phosphorylation after insulin treatment, the hypothesis would not be supported and 
suggest that Inh-1 and Inh-2 phosphorylation is either not important for PP1 regulation of 
AS160 dephosphorylation or is necessary, but not sufficient for PP1 regulation of AS160 
dephosphorylation. 
Specific Aim 6: If the post-exercise increase in insulin-stimulated glucose 
transport is reduced in mutated muscle vs. non-mutated muscle, the hypothesis would be 
supported and suggest that AS160 dephosphorylation by PP1 (secondary to increased 
Inh-1/Inh-2 phosphorylation) leading to sustained AS160 phosphorylation results in 
enhanced insulin-stimulated glucose transport post-exercise.   A working model is 
depicted in Figure 6.1. 
If the post-exercise increase in insulin-stimulated glucose transport is similar in 
mutated muscle vs. non-mutated muscle, the hypothesis would not be supported and 
suggest that AS160 dephosphorylation by PP1 (secondary to increased Inh-1/Inh-2 
phosphorylation) leading to sustained AS160 phosphorylation is independent of the 
mechanisms leading to enhanced insulin-stimulated glucose transport post-exercise.  
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Alternative Approaches 
PP1 regulatory subunit: If there are problems with the electroporation of the 
PP1reg-AS160 DNA or siRNA, we can assess the transfection in L6 myotubes.  
PP1 catalytic subunit:  If there are problems with the electroporation of the Inh-
1/Inh-2 phospho-mutants, the kinases of Inh-1 and Inh-2 can be targeted as they are well 
established.  Inhibiting the activity of the kinases on their ability to phosphorylate Inh-1 
and Inh-2 may be conducted via genetic manipulation or pharmacological intervention 
using known inhibitors.   
 
  
Overall Conclusions  
In conclusion, this dissertation investigated the mechanism of two endpoints 
resulting from the same initial intervention: the long-lasting effects of exercise on 1) 
insulin-stimulated glucose transport and 2) AS160 phosphorylation in rodent skeletal 
muscle.   The first part of this dissertation focused on the possible triggering mechanisms 
that lead to the post-exercise increase in insulin-stimulated glucose transport.  We 
hypothesized that mice that lacked the B2 receptor of bradykinin and rats that were 
deficient in plasma kininogen versus their respective sedentary controls would not 
develop an increase in insulin-stimulated glucose transport after a single bout of exercise 
in skeletal muscle.  However, these hypotheses were not supported suggesting that the 
KKS is not essential for development of increased muscle insulin sensitivity after in vivo 
exercise.   
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The second part of the dissertation focused on the mechanisms regulating a key 
signaling event that has been reported to occur concomitant with increased post-exercise 
insulin-stimulated glucose transport, sustained AS160 phosphorylation after acute 
exercise.  The results in this study demonstrated that not only is AS160 phosphorylation 
increased at the Thr642 site in rat epitrochlearis muscle, but it is also sustained at the 
Ser588 site. These results are significant because these are the two phopsho-sites 
important for the full effect of insulin-stimulated GLUT4 translocation (27).  The results 
of the study implicated AMPK as the AS160 kinase that is most likely to be responsible 
for the increased AS160 phosphorylation found in skeletal muscle immediately after 
exercise.  Additionally, the results of this study provided evidence that sustained 
phosphorylation of these AS160 phospho-sites after exercise is not likely regulated by a 
sustained increase in phosphorylation of any of the four known AS160 kinases (Akt, 
AMPK, RSK, SGK) on sites essential for their activity.   The results from this study 
further revealed that of the four most highly expressed serine/threonine phosphatases in 
skeletal muscle, PP1 and PP2C are both associated with AS160 and able to 
dephosphorylate AS160 immunoprecipitated from isolated skeletal muscle.  Future 
studies are needed to clarify the possible roles of these phosphatases for sustained AS160 
phosphorylation and to establish a role for sustained AS160 phosphorylation for the 
increase in insulin-stimulated glucose transport in skeletal muscle after acute exercise. 
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Figure 6.1 
PP1 and AS160 Working Model for Research Proposal.   
 
Abbreviations:  PP1cat: PP1 catalytic subunit, PP1reg: PP1 regulatory subunit, Inh-
1/2: Inhibitor 1 and/or Inhibitor-2.   
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Legend for Figure 6.1 (see preceding page) 
 
A) PP1 and AS160 under sedentary conditions with no insulin: Both AS160 kinases and 
Inh-1/2 kinases are inactive, Inh-1/2 is not phosphorylated, and PP1 is constitutively 
active favoring dephosphorylated AS160.  
 
B) PP1 and AS160 under sedentary conditions with insulin: Inh-1/2 kinases are inactive, 
therefore Inh-1/2 is not phosphorylated resulting in constitutively active PP1.  AS160 
kinase activity (Akt via insulin) is increased sufficiently to oppose constitutively active 
PP1, resulting in increased AS160 phosphorylation.   
 
C) PP1 and AS160 immediately post-exercise with no insulin: Exercise causes activation 
of Inh-1/2 kinases that phosphorylate Inh-1/2, which in turn renders PP1 inactive.  
Exercise causes activation of AS160 kinase (AMPK) resulting in increased AS160 
phosphorylation.    
 
D) PP1 and AS160 three hours post-exercise with no insulin: Exercise causes activation 
of Inh-1/2 kinases that phosphorylate Inh-1/2, which in turn renders PP1 inactive.  The 
immediate effects of exercise on activation of AS160 kinases (AMPK) have reversed, 
resulting in inactive AS160 kinases.  However, PP1 dephosphorylation activity is 
inhibited, resulting in sustained AS160 phosphorylation that had originally occurred 
because of the activation of AS160 kinase activity (AMPK) during and immediately after 
exercise).    
 
E) PP1 and AS160 three hours post-exercise with insulin: Exercise causes activation of 
Inh-1/2 kinases that phosphorylate Inh-1/2, which in turn renders PP1 inactive.  The 
immediate effects of exercise on activation of AS160 kinases (AMPK) have reversed, but 
insulin results in activation of AS160 kinases (Akt).  However, PP1 dephosphorylation 
activity is inhibited, resulting in sustained and enhanced AS160 phosphorylation because 
of the cumulative effects of activation of AS160 kinase (AMPK) during and immediately 
after exercise along with the subsequent activation of AS160 kinase (Akt) induced by 
insulin.    
 
F) PP1 and AS160 three hours post-exercise without insulin in muscles expressing Inh-
1/2 phospho-mutant: Exercise causes activation of Inh-1/2 kinases that phosphorylate 
Inh-1/2, but they are unable to phosphorylate Inh-1/2 phospho-mutants resulting in 
constitutively active PP1.  The immediate effects of exercise on activation of AS160 
kinases (AMPK) have reversed resulting in inactive AS160 kinases and, constitutively 
active PP1 favors dephosphorylated AS160.   
 
An assumption of this simple model is that PP1 is the only Ser/Thr phosphatase 
regulating AS160 dephosphorylation that is responsive to exercise-induced inactivation. 
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Figure 6.2  
Working model for prior exercise resulting in increased insulin-stimulated glucose 
transport in skeletal muscle.  This model describes the time-course and bioeffects 
associated with each step.  Studies 1 & 2 did not support the KKS as an essential trigger 
during exercise, whereas Study 3 provided support for phosphorylated AMPK as a 
possible trigger.  Study 3 supported sustained phosphorylation of AS160Thr642 and 
AS160Ser588 as memory element/mediator in the hours after exercise.  PP1 and/or PP2C 
may regulate AS160Thr642 and AS160Ser588 phosphorylation.  Prior research indicates 
increased cell-surface GLUT4 as an end-effector resulting in increased insulin-stimulated 
glucose transport.  AMPK pT172: phosphorylated AMPKThr172, AS160 pT642: 
phosphorylated AS160Thr642, AS160 pS588: phosphorylated AS160Ser588,   GLUT4: 
glucose transporter 4, KKS: Kallikrein-Kininogen System.  
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